Potency	4639105
IC50	2738742
GI50	1930878
Inhibition	1209213
Activity	1131700
Percent Effect	932020
MIC	766307
Ki	664994
EC50	471813
INHIBITION	339133
AC50	292196
Tissue Severity Score	257998
ED50	167629
GI	164836
Ratio	155950
Kd	151799
Residual Activity	147888
IZ	124157
Ratio IC50	110485
CC50	85372
T1/2	77067
LC50	57773
CL	55193
FC	48758
TGI	46378
Solubility	46359
mortality	44137
Stability	43514
WEIGHT	37735
Drug uptake	36994
Ratio Ki	34851
AUC	33107
ID50	32799
Emax	29264
LogD	27197
F	26630
MIC90	26556
T/C	26539
LogP	26222
Drug metabolism	26018
MIC50	24965
Efficacy	23776
Cmax	22868
Selectivity	21971
Change	20856
BUN	20532
ALP	20494
ALT	20488
AST	20484
POTASSIUM	20481
CHOL	20479
GLUC	20479
CREAT	20479
PHOS	20479
ALB	20479
PROT	20477
SODIUM	20475
BILI	20317
LUCIFERASE INFECTION ASSAY - IC50	19978
LUCIFERASE INFECTION ASSAY - IC90	19978
HEPG2TOX ASSAY - CC50	19978
HEPG2TOX ASSAY - CC90	19978
LUCIFERASE EXPRESSION CONTROL - IC50	19978
LUCIFERASE EXPRESSION CONTROL - IC90	19978
LDH	19768
TIME	19729
IFI	19230
Survival	19209
LD50	19173
WBC	19139
RBC	19019
MCHC	19014
MBC	19004
HCT	18999
MCV	18998
HGB	18993
MCH	18989
PLAT	18962
NEUTLE	18932
EOSLE	18932
BASOLE	18932
MONOLE	18932
LYMLE	18932
Ratio EC50	18608
Selectivity ratio	17713
Control	17324
Selectivity Index	16820
pKa	16751
Ratio CC50/EC50	16267
IC90	15445
Reduction	15177
Delta Tm	15175
Papp	14225
MIC80	13892
XC50	13557
permeability	13207
Concentration	12977
Cl	12783
GGT	12747
ALBGLOB	12737
TRIG	12733
PHOSLPD	12733
CALCIUM	12733
BILDIR	12685
MED	12546
Vdss	12456
Relative potency	12098
ILS	11862
APTT	11719
RETIRBC	11255
PT	11218
Tmax	10959
FIBRINO	10848
MFC	10753
Fu	10741
RBA	10033
Km	10032
Kb	9983
TERMBW	9546
Ratio CC50/IC50	9273
Intrinsic activity	9211
CLH	9121
solubility	8861
DIZ	8631
PPB	8462
MIC99	8359
Ac50	8341
Cp	8194
CLogP	8121
ID/g	7992
CHLORIDE	7738
Cytotoxicity	7560
MST	7484
Imax	7434
K	7432
CK	7432
MCC	7312
-logMIC	7309
TI	7001
LIPASE	6920
URATE	6918
CO2	6740
BASO	6662
%max	6621
EOS	6614
LYM	6614
MONO	6614
EC90	6509
NEUTSG	6402
Decrease	6338
TC50	6297
RBCNUC	6222
TD50	5750
Relative activity	5702
Vmax	5506
Selectivity index	5493
Survivors	5479
PD50	5468
Log 1/C	5380
Diet	5330
Toxicity	5125
DOSE	4985
Ke	4933
INH	4929
Delta MST	4875
Increase	4760
Protection	4732
MEC	4259
AbsAC35	4257
Effect	4227
pKb	4069
Vd	3953
Ka	3931
IC50 ratio	3929
Hepatotoxicity	3929
pKB	3890
log2FC	3808
MTD	3805
ID/organ	3798
pD2	3722
Dose/organ	3696
FICI	3574
AbsAC40	3556
BP	3473
OD	3444
SI	3398
MIC>99	3395
Log K	3357
MRT	3295
Dose/g	3276
Duration	3263
Dose	3225
Weight change	3219
Max	3113
Response	3094
Displacement	3062
K obs / 1	3027
Biodistribution	3005
BPR	3004
Retention_time	2922
t1/2	2839
ED90	2611
Diuretic activity	2599
Motility	2497
Cures	2492
AbsAC40_uM	2483
Growth	2476
IC95	2462
CD50	2440
Hepatotoxicity (moderate)	2432
Hepatotoxicity (acute)	2432
Residual activity	2415
Tm	2401
Kcat	2325
CI	2321
K app	2233
Kinact	2179
ED30	2170
Kcat/Km	2148
MTC	2139
Decrease in blood pressure	2136
PI	2128
Stimulation	2067
KA	2044
AD50	2038
Therapeutic index	2038
Distribution	2038
AUC/dose	1988
RatioGI50	1981
Delta mean survival time	1947
EC	1920
NT	1920
Injected dose	1904
RatioLC50	1903
ERH	1900
IC80	1897
pIC50	1894
MIC=>90	1880
Activity_index	1879
MIC95	1864
Peff	1859
DILI_severity_class	1858
DILI_Concern	1858
Rate of inhibition	1841
Log 1/MMIC	1836
ED20	1827
Compound recovery	1812
Drug recovery	1790
MIC100	1786
log K	1750
Variation	1707
PXC50	1705
Relative binding affinity	1704
No. of survivors	1704
Max response	1700
Heart rate	1692
Inhibition index	1691
IA	1682
Potency ratio	1681
Hit score	1669
ILSmax	1666
Drug degradation	1662
Mortality	1661
Injected dose/g	1651
max activation	1649
AFI	1641
Delta TC	1641
Activation	1634
Log2 MIC	1629
Radioactivity	1615
HR	1610
Reversal	1610
k obs / 1	1610
Ratio TD50/ED50	1607
No. of cured mice	1602
Binding	1601
Log 1/D50	1568
Log 1/LD10	1552
C50	1545
Viability	1530
AbsAC1000_uM	1515
Suppression	1510
Radiolabel recovery	1493
Animals	1489
ED	1484
SUV	1474
Decrease in SBP	1473
NA	1465
K ass	1420
ID	1399
Ratio IC50/EC50	1378
Level	1370
Optimal dose	1338
Activity rating	1337
Virus rating	1326
log(activity)	1311
Recovery	1308
k cat	1288
Ratio ED50	1266
HC50	1259
Saluretic activity	1254
Relative IC50	1250
Zone of inhibition	1247
Log k'	1241
deltaT	1233
Phytotoxicity	1233
Paw swelling	1229
UI	1219
Affinity	1218
Hepatotoxicity (cirrhosis)	1216
Hepatotoxicity (granulomatous hepatitis)	1216
Hepatotoxicity (association with vascular disease)	1216
Hepatotoxicity (steatosis)	1216
Hepatotoxicity (malignant tumour)	1216
Hepatotoxicity (benign tumour)	1216
Hepatotoxicity (animal toxicity known)	1216
Hepatotoxicity (successful reintroduction)	1216
Hepatotoxicity (comment)	1216
Hepatotoxicity (time to onset)	1216
Hepatotoxicity (mechanism)	1216
Hepatotoxicity (cytolytic)	1216
Hepatotoxicity (choleostasis)	1216
Hepatotoxicity (severe hepatitis)	1216
Hepatotoxicity (chronic liver disease)	1216
pA2	1212
EDmin	1202
AbsAC35_uM	1200
k_off	1184
DC50	1171
Kis	1171
IP	1162
Plasma level	1155
Locomotor activity	1146
Log 1/Ki app	1142
Delta blood pressure	1130
CD	1116
LC90	1113
Rm	1112
Max fall in blood pressure	1108
Log Ki	1097
log10cfu	1094
TDI	1094
Diameter of inhibition zone	1088
PC50	1073
ED25	1062
Cp(f)	1025
Kp	1020
k_obs	1019
Block	1006
Relative affinity	1005
pEC50	1002
logPapp	996
GR80	996
Anticonvulsant activity	989
T-C	983
EC25	977
Permeability	975
Flu intensity	974
MSD	972
No. of revertants per plate	960
kon	958
HD50	955
pED50	950
Retention time	948
FDI	943
EC30	943
Inhibition zone	938
Drug excretion	936
Ratio AUC	934
Mean injected dose/g	921
Effective dose	906
Delta IOP	901
KE	897
-Log KB	891
IC30	884
CL_renal	881
Incorporation	880
K(p,uu,brain)	866
Weight difference	863
K inact	862
Viable cells	862
k'	845
Phospholipidosis	842
Cooperativity	842
Delta TM	834
Kinetic_solubility	833
k	833
Kii	831
pKi	825
Ki ratio	825
logIC50	823
APD95	822
MABP	817
I.D./g	810
delta logD	810
ILS max	808
Body weight	804
No. of animals	802
Drugexcretion	793
Inhibitory activity	790
ED40	788
Injected	788
log(43000/Ki)	780
MBC99.9	776
Survival time	774
Fold reversion	774
MIC=>80	769
Score	767
Amnesia reversal	765
LD10	757
RA	751
k_on	750
Hill coefficient	747
AP	744
MLC	735
deltaTm	735
Safety ratio	734
GR50	732
Plasma concentration	732
Urine volume	732
PFA	727
MLD	726
No. of mice cured	724
I50	719
P	715
MPE	709
Average weight change	703
SDL	699
Binding affinity	697
Mean survival time	695
MIC>90	694
Parasitaemia	690
Log IC50	686
k cat/Km	684
Bmax	680
Delta HR	679
Schizont size	678
Cmin	677
Metabolism	673
GI90	671
Relative Vmax	671
CL/F	664
LD90	661
HC10	655
Retention	655
log Pe	654
LTS	654
MBEC	642
Average weight	642
Max_Activity	640
Repellency	636
Growth inhibition	633
Ratio Ki(app)	631
Ratio pIC50	631
Complex formation	631
pKa2	629
Cured	629
Antagonism	621
EC1.5	617
pCC50	615
Max inhibition	615
Relative efficacy	615
MBC>99.9	614
log(1/C)	613
IOP	613
Median survival time	612
Acquisition time	612
BWD	609
VR	609
Solubility ratio	609
k3/Ki	608
Delta MAP	605
ED100	603
CCIC50	603
Rmax	598
Estrogenic effect	598
IC20	596
pKD	596
Hydrolysis	595
ED80	594
RF	593
Toxic deaths	589
K2	587
LCK	585
Rate	585
Log S	583
LC99	583
k2	582
Change in amplitude response	579
Relative viability	576
Relative SEAP activity	576
pKa1	572
MPC8	568
Sleeping time	567
pI50	566
D	564
Excretion	564
EC80	563
MAP	563
-Log C	563
Emetic episodes	561
Glucose normalisation	561
fCmax	560
ED50 ratio	560
Rate constant	553
Distribution of radioactivity	552
Weight	551
TPE	547
Polyamine	546
Mole fraction	546
IC25	544
pLD50	543
Ratio pKi	542
MFC99.5	542
Aggregation	540
Oral activity	539
IC100	536
I	533
Change in BP	533
FIC	532
Max stimulation	532
Blood glucose	531
D50	530
CT	530
CF	528
FPD measurement	527
MNEC	525
Crop_yield	525
MES	522
Taq inhibition	522
-Log ED50	520
NI	519
Relaxation	516
Disease control	513
Antagonist potency	510
log10CFU/ml	508
Lowering	506
Lethality	503
Delta G	503
Mean survival	502
AB50	501
PGI	501
Tumor volume	500
Drug uptake(free)	498
Average skin reaction	498
kinact	497
P50	497
log(1/MIC)	494
Blood pressure	494
pKA	494
Efficiency	492
RRT	492
MNCC	491
MBP	491
R	491
MOTILITY REDUCTION/CYTOTOXICITY	491
GGT Increase - Index Value	490
LDH Increase - Number of Reports	490
GGT Increase - Activity Score	490
GGT Increase - Number of Reports	490
Composite Activity - Score	490
Composite Activity - Active	490
Composite Activity - Marginal	490
Alkaline Phosphatase Increase - Activity Score	490
Alkaline Phosphatase Increase - Index Value	490
Alkaline Phosphatase Increase - Number of Reports	490
SGOT Increase - Activity Score	490
SGOT Increase - Index Value	490
SGOT Increase - Number of Reports	490
SGPT Increase - Activity Score	490
SGPT Increase - Index Value	490
SGPT Increase - Number of Reports	490
LDH Increase - Activity Score	490
LDH Increase - Index Value	490
ID x kg of body weight/g of tissue	486
MTL	485
Accumulation	485
log Ks	484
Survivals	483
MBC99.5	482
Time	479
Range	478
No. of survivals	477
LC80	474
Relative uterus weight	474
GABA shift	472
C20	472
Fa	471
Relative ED50	471
K0.5	469
Serum Ca2+	467
Number	465
-Delta G	465
MIC>95	464
C10	462
Ks	460
RIS	460
Protected	457
Log 1/M	457
FRP	456
Reduction of live worms	456
Cell growth	455
EC20	454
T	451
pRA	450
Release	448
TDS	448
Survivors at day 4	447
Occ	444
Specific activity	442
Change in weight	441
Oral diuretic activity	441
SVT	441
Mean arterial blood pressure	440
Body weight change	439
Uptake	438
Agonist potency	438
2PT	436
nH	436
Enhancement	436
GE	436
RFU	435
Activity scale	435
ISA	432
Licking latency	432
Log EC50	431
CHI	430
Index	430
CMC	427
Formation	424
CC25	423
Log RA	422
Log 1/MIC	421
Ct	420
Uptake ratio	419
GABA ratio	417
Uterine weight	417
pKi(uM)	417
Cleavage	416
Partition coefficient	415
Leishmanicidal activity	414
No. of mice	414
RLU	411
MHC	411
RI	411
Cell survival	409
LC70	408
CFU	406
No. of cures	406
No. of toxic deaths	405
Normal beats	405
Rating	405
MFC99.9	403
Resistance factor	401
ED1.5	401
MPR	400
Contraction	400
ED2	399
No. of positive cases	399
MID	398
log(%)	398
MBIC50	398
fAUC	397
Vd/F	396
Reversion	396
Equieffective dose	396
Diuretic effect	396
Drug release	395
AbsAC1	395
KSV	393
Zone size	393
Change in heart rate	392
MGM	391
V	390
Amount excreted	390
Log BR	390
Fall	389
LAD	384
Cell viability	382
Vmax/Km	381
Decrease in activity	381
XI50	379
2aPTT	378
Max salt tolerance	378
Ratio Ke	377
No. of cells	377
log(1/MLD)	375
Decrease in Systolic blood pressure	375
ED10	373
Survival rate	373
LED	372
Tissue distribution	370
FR50	369
Time constant	369
P50e	368
Log 1/MEC	366
TT	364
p[A50]	364
Weight change difference	363
Relative amplitude	363
KL	362
Remaining	361
FPDc	361
Fold increase	360
CC20	357
Mean blood pressure	356
Total radioactivity	355
Duration of action	354
ND50	354
HI	351
Blood sugar lowering	351
CC90	350
Therm_solubility	349
Enzyme activity	349
Binding energy	347
NE	343
EMR	342
EC200	341
Relative Potency	341
Hypoglycemic activity	340
MNTD	339
Conversion rate	339
Secretion	339
Cholesterol reduction	339
Systolic blood pressure	338
Max effect	337
deltaH	337
MBIC	336
Serum level	336
EC150	334
Agonism	334
LD0	333
Q	333
Kr	333
Ratio LC50/IC50	332
LogD7.4	332
ED99	330
fT>MIC	330
Entry latency	330
NS	328
Weight loss	325
Response ratio	324
Alpha max	323
KB app	323
kHOX	321
IVP	321
Kel	318
Fluorescence	318
K inact/Ki	318
No. of rosettes/100 Jurkat T cells	318
Increase in blood pressure	317
Fh	316
Fg	316
Log 1/T	316
PF50	315
Toxic dose	314
Parasitemia	313
A50	312
Latency	312
MIC=>95	310
F_fraction	308
Production	308
Change in blood pressure	308
Beta2 duration	306
Cures/total	303
SMT	303
MIC>98	300
Cures/no. of animals	300
Absorption	300
No. of sensitive	300
Culture	300
Sensitivity	297
Inhibitory index	297
Adhesion	297
behavior	297
Log 1/K	297
EC50 ratio	296
deltaG	296
ID50 ratio	295
Analgesia	294
IC70	294
Amount of TNF-alpha	294
Average dose per organ	294
Onset	293
Tumors	292
Hypersensitivity factor	291
Specificity	291
Relative protection	290
Turnover	290
EC100	289
Serosal/Mucosal Ca	288
Max reversal	288
Mean relative potency	288
IC12	287
SD90	286
HCR	286
Toxic	285
DA release	285
D10	284
TC	283
log(1/BC)	282
pIC25	282
K1	282
Log 1/D40	282
Plaque reduction	282
Drug transport	280
APD	279
Relative velocity	278
Log Kd	278
CLogD	277
NOAEL	276
pKa3	276
Increase in ear thickness	276
Resistance index	275
No. of mice protected	275
No. of tumors	273
Excretion Na+	273
Excretion K+	273
Excretion Cl-	273
HACU improvement	273
CTD50	272
LD100	272
Wet weight of tissue	272
Mean	271
Mean urine volume	270
Mean excretion of Na+	270
Mean excretion of K+	270
Mean excretion of Cl-	270
Polyamine level	270
Am	270
LD20	270
Estrogenic potency	269
LC95	268
dP/dt	268
Average survival	268
Antagonist activity	267
Geometric mean	266
Antifertility potency	266
Smax	266
Kapp	265
MPC	265
MBC90	264
PDK	264
Kinetic constant	264
CCTD50	264
mean log D	264
Zone diameter	264
Brain content	264
Increase in life-span	263
Agonist activity	262
ED95	262
Total cholesterol	262
ED85	261
pXC50	261
PAE	261
Metabolic stability	261
Glucose transport	261
Kq	260
Mutagenicity	260
Delta SBP	260
Max increase	260
Basal uptake	260
IG50	259
Clearance	259
ALD50	258
Revertants/plate	258
HYPO	258
C0	257
Temperature	257
Relative EC30	257
IR	257
koff	257
Css	256
Inhibitory diameter	256
KB	255
Inhibition rate	255
Antibacterial activity	255
Activity index	254
Mean survival days	252
Plasma content	252
MIC=<90	252
TCID50	251
p[A]50	250
kOX	250
CT10	249
Toxicity ratio	249
Relative JC-1 accumulation	249
Cmax/dose	248
logP(lung)	248
Saldiuretic activity	247
Blood level	247
Ke(app)	247
Na	246
Fibril formation	246
Decrease in AP	246
Log kOH-	245
T50	244
DD	244
Injected dose/organ	244
Potentiation	242
Kinetic	242
Kdiss	241
Volume	241
TI50	241
Taste	241
ALP activity	240
CMP	240
Susceptibility	240
Lipid level	240
Protective index	239
ACT	239
Protection index	239
Delta t	239
BP decrease	239
Average IC90	238
Fold selectivity	237
SC50	236
Conversion	236
Relative amount	236
S	234
HF	234
x fold	234
IF	234
pK	234
AA	234
Baseline systolic BP	234
Na+ excretion	232
LTC	232
Death	232
Rf	231
DRF	231
Peak rhGH	231
2x APTT	231
P50c	230
Decrease in CR	230
Change in Cl- current	230
EC99	229
Analgesic activity	229
T/C x100	228
TI rating	228
Fabs	227
Loss	227
Survival ratio	227
MAD	226
ID90	226
MPE50	226
logKw	225
CyD50	225
HSAI	225
MAC	224
log(RatioIC50)	224
Absorbance	224
Lactone	224
Tumor weight	224
Log kill	223
MGC	222
K 0.5	222
BWC	222
Swelling	222
AUClast	221
Lysis	221
logPeff	221
Hemolysis	220
Hypothermic effect	220
deltalog(Tau/KA)	220
DNAUC	220
pGI50	219
Recovery time	219
Drug discrimination effect	219
Supression	219
Log [MrI]	219
Bioreduction	219
LLR score	218
ED15	217
BK	217
Log SP	217
GR	216
EC15	216
Excretion rate	216
Blockage activity	216
CPE index	216
TR	215
CCh	215
logKi	214
MFC90	214
IC10	213
Log CR	213
LS	213
Inhibitor level	213
Mouse behavior activity	213
Serum concentration	212
Log kon	212
Relative stability	211
Ulcerogenic index	210
GHI	210
Ka'	210
Ki/KI	210
Change in IOP	210
Esc loss	209
Normalization	209
Growth_index	208
LD99	208
EII50	208
Log cell kill	208
Iron change	208
Proliferative response	208
Residual_activity	207
C20 APD95	207
Log BB	207
Survivors / animals tested	207
Temperature change	207
Change in reaction time	207
Slope	207
SS	207
Log Pe	207
Collapse time	207
MD	207
APD75	207
CLH(app)	206
pKa4	206
TG100	206
TOP	206
BOTTOM	206
HILLSLOPE	206
Therapeutic ratio	205
BA	205
Liver weight	205
IC16	204
Decrease in blood glucose	204
Diameter	204
Log relative k'	204
Antibiotic activity	204
PCA	204
Protein-DNA complex formation	204
fIC50	203
Antitumor activity	202
GDP ED50	201
No. of emetic episodes	201
Inhibitory potency	201
RIA	201
ED150	201
Mean weight	201
REC	201
Mean peak APTT	201
delta pIC50 wt-mutant	200
CCID50	200
Krel	200
Survival days	200
PCMA antagonism	200
AUCt	199
Kic	199
K obs	199
IFN	198
[I]	198
Iron output	198
Extracted	198
Edema variation	198
Decrease in QA interval	198
Taste character	198
Change in response	198
Toxic level	197
Inactivation	197
Mean aortic blood pressure	196
SP	196
AOA	196
Pc	196
Hammett constant	196
Decrease in MABP	195
SRR	195
Potency_Clk4_uM	195
Reversal activity	194
Lipophilicity	194
No. of Colony forming Units	193
Ratio pA2	192
Discrimination ratio	192
UR	192
Delta HDL	192
Life span	192
Sweetness potency	192
Radius of inhibition zone	192
ITP	192
AC3	192
Metabolite level	192
log KOW	190
QH	190
RE	190
Pmax	190
ka	189
Benzidine positive cells	189
Edema	189
-Log KD	189
Change TC	189
AZT formation	189
Average tumor volume	189
I ABC	189
Inhibition uptake	189
Log activity	189
Kin	188
Brain level	188
H2O2 prot	188
Delta A/min	188
Ratio pKb	187
MBC50	187
Max non-toxic dose	186
Emin	186
Hydrolysis rate	186
Log RAI	186
TN	186
PHA	186
ED200	186
Radiation prot	186
pK1	184
ND	184
Blood flow	184
Glucose utilization	184
Vmax / Km	183
Significance	183
DeltaTC	183
MDD	183
Organ distribution	183
dP/dt20	183
Resistance	183
Potency_Clk2_uM	183
GC50	181
ED300	181
Organ weight	181
Hill coefficient (n50)	181
Parasite_Clearance	181
Stimulation index	181
Chemotherapeutic index	180
PCA shift	180
DAR	180
Baseline	180
Weight gain	180
Sensory evaluation	180
MG MID	180
kDPPH	180
Total iron output	180
A10	180
Uterotrophic effect	179
RD500	179
ki/Ki	179
Fold activation	179
Delta BG	179
GS	178
Cells	178
Log koff	178
Inhibitory zone	178
MI0.5	177
Expression	177
Other	177
Max PI	177
FSC	177
Induction	176
K(p,uu,CSF)	175
EH	175
Relative salidiuretic activity	174
Reduction factor	174
Co	174
Activity ratio	174
Tp control	174
Zone of stimulation	174
ERP	174
Neuroprotection	174
AE Score	174
Log kw	173
BWLmax	172
Cholesterol	172
Result	172
Increase in IC50	172
MLD50	172
Dose ratio	171
MBIC90	171
log(1/LD50)	170
Latency time	170
Max delta APD95	168
Therapeutic index 99	168
Median life span	168
pRA2	168
% absorbed	168
pRA1	168
Proliferation	168
Modification	168
Phorbol displacement	168
ECS ratio	168
IS	168
Neurotoxicity	167
MCC50	167
Apoptosis	167
Ratio LD50/ED50	166
RBF	166
-log(inh/100-inh)	165
AFC50	165
DOPA accumulation	165
Reactors/Test group	165
ID75	165
Methemoglobin	165
EDMES(2.5)	165
Log 1/EDMES(2.5)	165
Dead cells	165
Platelet aggregation	165
Reaction time	165
PO2	165
Serum total triglycerides	165
Removal of microfilariae	165
-log(RatioIC50)	164
Synergy	164
Uptake value	164
CC100	163
K Bind	163
Plasma glucose	163
Change in Tm	163
Change in body weight	163
deltaA	162
C1.6	162
Amount	162
pK2	162
Initial activity	162
No. of falls	162
No. of lung colonies	162
Rise HR	162
PFC	162
Fold resistance	162
Relative ID50	162
Delta APD90	162
nHill	162
Log ED50	162
Change of tumor area	161
Loss of righting reflex	161
&#256;	160
Max decrease	160
Behavioral score	160
Median day of death	160
Growth delay	159
Behavioral effect	159
Ataxia	159
Punch weight/MPO activity	159
log10(%HIA +10)	159
PBI	158
AWC	158
Ulcer incidence	158
Triglycerides	157
C	157
TCS50	157
IC	156
MED50	156
VERP	156
Eye toxicity	156
Distribution coefficient	156
-Log Kdiss	156
Quantity	156
Fraction experiencing seizures	156
GM-MIC	156
Delta p	156
Protective effect	156
Mitotic index	156
Receptor occupancy	156
Rhodamine-123 accumulation	156
MISS T/C	156
mechanism based inhibition	156
Max T/C	155
MOT	155
Log D50	154
No. of animals protected	154
RAC	154
fAUC/MIC	153
Aneuploidy activty	153
Acceptor activity	153
Bound	153
Competition factor	153
cAMP activity index	153
Relative inotropic potency	153
Activity of control	153
Antiovulatory activity	153
-Log ID50	152
Affinity constant	152
Log Kmemb	152
pTC50	152
Transfection efficiency	152
Max reduction	151
Safety index	150
FBP mean score	150
FT mean score	150
Delta pH	150
Rate of O2 consumption	150
Total excretion	150
Modulation factor	150
Reversion activity	150
Beta-lactamase induction	150
Log 1/ratio	150
BDW	150
DOM	149
Saluretic potency	149
pH	148
Shift	148
Cured/treated	148
EC95	147
pTI	147
Accumulated counts	147
Ks/i	147
Immobility time	147
Degradation	147
Surviving fraction	147
Delta TAO	147
Net cell kill	147
EC40	147
Fold induction	147
Log 1/I50	147
Log A	147
Length	147
pEC100	147
TBPS shift	147
Kiuc	146
N	146
K aff	146
Ki 0.5	146
No. of rabbits convulsed	146
pka	145
Serum cholesterol	145
AR	145
UD50	144
Relative agonistic activity	144
Binding activity	144
Tm shift	144
Skin tests intensity	144
Behavior score	144
Cytoprotective effect	144
No. protected/tested	144
No. of counts	144
P ABC	144
Irritation	144
K bind	144
Increase in footpad thickness	144
Efficacy index	144
Responding	142
[35S] TBPS shift	141
Mean IC50	141
Response rate	141
Incidence	141
Urinary recovery	141
CBF Ratio	141
Pgp AbA/analogue ratio	141
FBF Ratio	141
E	141
Max delta HR	141
% recovery	141
Selectivity quotient	140
Ki app	140
LogD6.5	140
CC10	140
EC2x	140
PI turnover	140
Glyceamia evolution	140
Vmax(app)	139
PF	139
Inhibition potency	139
Vigour_index	138
CT50	138
C175	138
Acute toxicity	138
Mydriasis	138
Log M50	138
Log ILS max	138
Inhibition ratio	138
Variation/Control	138
Log SOSIP	138
Tissue concentration	138
REP	138
Relative ET-A IC50	138
Total dose	138
Diuretic effects	138
pTGI	137
pA10	137
C/I ratio	137
Brain concentration	136
Vasorelaxant effect	136
pC1	136
No. of dead mice	135
Foci/dish	135
ka/Ki	135
Days	135
Change in body temperature	135
Free	135
Relative F%	135
LV FRP	135
Binding constant	135
Possible response	135
Apparent enzyme activity	135
Ki(app)	134
RP	134
Convulsion	134
ov. rat/total	134
[3H] concentration	134
LT50	133
Antidiuretic activity	133
AUC N	133
No. of mice survived	132
Relative resistance	132
RSA	132
Active dose	132
Protected mice	132
No. of deaths	132
LVP	132
CPP	132
pA2/pKB	132
Nuclear cataract	132
P50d	132
CFU/ml	131
MFC50	131
ID40	131
Plasma insulin	131
Motor activity	131
log(ratio)	131
PC	130
pMIC	130
G30	130
Mean uterine weight	130
P (Ei)	129
Net log cell kill	129
REA	129
Potential	129
EPMR	129
Deaths	129
LD5	129
k3/ki	128
CRC/CRC0	128
Tracer	128
logFu	127
Lethal dose	127
pC	127
log(permeability)	127
RatioAUC/MIC	126
No. of chicks	126
C24	126
Separation	126
Max change in blood pressure	126
No. of cured	126
Capacity	126
RTW	126
Cell protein	126
Csat	126
Csat/Co	126
RHT	126
Cl - current change	126
Kieq	125
MTC50	125
CAR	125
Alpha E	125
Delta APD95	124
CPA	124
Fm	124
I90	123
MDD50	123
Max CF response	123
Median survival day	123
PL	123
Migration index	123
Log C	123
Lw/Bw	123
V0	123
CL free	122
Relative growth	122
KD/Ki	122
MRT(t)	122
Distribution (dose/g)	122
CC	121
dP/dt max	121
Tumor response	121
Average survival (days)	121
EC2	121
ECI	120
Average	120
Delta Vmax	120
Delta MABP	120
Aspirin formed	120
Inhibitory concentration	120
Kpot A,B	120
ASF	120
ED99.9	120
Activity in animals	120
RPF	120
Cytokine induction	120
Body weight reduction	120
Mean no. of revertants	120
Delta ERPc	120
Luciferase activity	120
Dose excreted	120
NC	119
SER	119
Ki'	119
Biological activity	119
Anti-pent effect	118
Injected dose/g tissue	118
Erythroid induction	118
MRC	118
No. of animals protected/animals tested	118
Delta pCa50	117
Min effective dose	117
D150	117
DNA	117
Average dose	117
Flea	117
Topical potency	117
Max delta MAP	117
kr	117
TFS	117
Mean body weight	117
Relative inhibition	116
IAr	116
EC5X	116
Potency_Dyrk1b_uM	116
Pm	115
Log K1	115
scMet	115
Cell number	115
deltalog10CFU	114
Max delta	114
Permeability coefficient	114
Log PR	114
Broncho selectivity	114
Body weight gain	114
PDH active/PDH total	114
Dose/g of tissue	114
pKp	114
SD	114
Relative luciferase response	114
Lesion length	114
K aps	114
Max delta FRP	114
Stool output	114
Total activity	114
Turns	113
TG	113
R%	113
Drugabsorption	112
RUmax	112
IC99	112
log10CFU/g	112
Improvement	112
Efficacy ratio	112
GTP shift	112
TGIR	112
pA50	111
Presynaptic antagonism	111
Postsynaptic antagonist	111
SBP	111
A1 selectivity	111
Hmax	111
H ABC	111
Mu/kappa ratio	111
Test/control survival	111
Delta T	111
Dose-modifying factor	111
LC100	110
NO release	110
Reactivity	110
Anti-fighting behaviour	110
Clined screen test	110
Log AP	110
NO formation	110
pIC50(app)	110
Ratio LD50/IC50	109
BBR	109
ECmax	109
cAMP production	109
MIC70	109
logLD50	108
AbsAC30	108
36Cl- uptake	108
Thymidine shift	108
Relative inhibitory potency	108
Exp Inhib Constant	108
Sensitized animals	108
MIC50/MIC90	108
RVR	108
Relative toxicity	108
Log k'w	108
Active dose range	108
Transport rate	108
Formation of NO2-	108
Enzyme level	108
Initial rates	108
Plasma GH release	108
Delta pKi	108
Delta/kappa	108
CMR	108
RC10	108
30 day survival / total	108
G index	108
Delta cpm x10e-3	108
Degradation rate constant	108
Rotation number	108
Arterial pressure	108
MED=>50	108
Na+/K+	108
Relative hydrolysis rate	108
Taste class	108
Polyamine content	108
Analgesia duration	108
Log GI50	106
Glucose level	106
RAC app	106
Max/average	106
MBC=>99.9	106
Delta HR50	106
Minimal dose	105
Others	105
2x aPTT	105
McPhail index	105
Log	105
FSC recovery	105
Control current	105
Log TCID50	105
-logKa	105
pAlpha	105
p alphaKa	105
TMP.decrease	105
Relative rate of hydrolysis	105
RC50	104
Tox50	104
Cardiotoxicity	104
Relative susceptibility	104
Rectal temperature	104
PTD50	104
rIC50	104
Ratio LD50/EC50	103
PB	103
Antimalarial activity	103
Median T/C	103
Specific binding	103
Remaining activity	103
log(ratioKi)	103
log1/IC50	103
HVA level	102
KH	102
SH level	102
k0	102
Activity A	102
Drug concentration	102
Rate of decomposition	102
TAR	102
CTS	102
Rolipram activity	102
Delta Gsolv	102
Bapp	102
Currents	102
No. of retches	102
Cell cycle analysis	102
Range of survival days	102
Delta	102
Change in systolic pressure	102
packed cell volume	102
ascites volume	102
MIC=>50	102
mequiv of Na+/kg	102
IC5	101
MPC4	101
Affinity ratio	100
Delta Fmax	100
No effect dose	100
pEC90	99
Cytokinetic response	99
Loss of cells	99
Catalepsy	99
T/C min	99
AE activity	99
Log k	99
ED Arec	99
Accumulation coefficient	99
Tremorolytic dose	99
MA	99
Relative inhibition index	99
ISC	99
Specific index	99
-Log 1/Kb	99
ED 50	98
Antihypertensive activity	98
Contragestational activity	98
APDc	98
% remaining	98
Antiviral effect	98
Reactivation	98
DNA cleavage	97
LogPapp	97
Tubulin binding	97
DNA binding	97
pKapp	97
Delta ERP	97
HDL-C	97
RH	96
pkB	96
Basal	96
DA response	96
Plasma lipids	96
Dry weight	96
RBA1	96
RBA2	96
Max drop	96
BP increase	96
EC0.01	96
MRF	96
No. of platelets	96
Plasma GH	96
Cell no/dish	96
No. of circlings	96
Differentiation	96
IC15	95
LC30	95
MMC	95
Relative rate	95
Log K'	95
Initial blood pressure	95
3 log kill	95
pLC50	94
EC37	94
Change of body weight	94
Log 1/LD50	94
AI50	94
Cytotoxic concentration	94
Virus yield	94
increase in mean survival time	94
Mean latency	94
Survivors at day 9	93
%	93
Non-HDL-C	93
T max	93
Effective concentration	93
ED35	93
Insulin release	93
Time above IC50	93
Log Kw	93
EC0.25	93
pEC0.5	93
Relative PT	93
Cured animals	93
SSC	93
FL-1	93
Fluorescence activity ratio	93
Max possible effect	93
Delta FC	93
Average change in body weight	93
RU	92
LDL cholesterol	92
HDL cholesterol	92
MDR ratio	92
Analgesic efficacy	92
IC90 mutant/IC90 WT	92
EC10	92
TdeltaS	92
MITC95	92
Fold-induction	92
AbsAC50	92
beta t1/2	91
Log Ko	91
FA	91
log(1/I50)	90
Ki/Km	90
Deaths/total	90
T/C 1	90
Dissociation constant	90
ID (per g of organ)	90
Metabolite levels	90
A2 selectivity	90
Kreact	90
pD'2	90
Speed of induction	90
Cardiac force	90
Mean time to seizure	90
Phototoxic effect	90
PTZ protection	90
T/V	90
T inh	90
GM	90
Basal inhibition	90
Acute electroshock activity	90
Inhibitory response	90
pMIC50	90
Average consumed	90
Biliary excretion	90
No. of animals with liver necrosis	90
logK(lung)	90
AC40	90
FI	89
Unchanged	89
MI	89
ADI	89
MIC=<50	89
FIC50	88
Competition	88
Tumor size	88
Survival range	88
MI100	88
K+ excretion	88
L/CE	88
Ki ss	88
Change in response rate	88
Ki''	88
Lipid-soluble radioactivity	88
Administered dose	88
logK(blood)	88
CTE	87
Kn	87
Rate of formation	87
pLADY	87
RM	87
ED ratio	87
NCC	87
RV	87
Feed consumption	87
Feed efficiency	87
MPO release	87
Antibody stimulation	87
Binding ratio	87
Net log kill	87
pC3	87
-Log K0.5	87
BFU	87
CLIP	87
Nr/N	87
Relative change	87
Reversible	87
AbsAC90	87
Judgments	87
Ovulating rats	87
Tlast	86
k2/Ki	86
Plasmaconcentration	86
Inhibition over time	86
Deoxyribose degradation	86
ILS30	86
No. of rats ovulated	86
Influx	86
Vdu	86
Uterine wet weight	85
MUD	85
Fmax	85
-TdeltaS	85
Root_galling_index	84
Urinary volume	84
CPE50	84
Anti-uterotrophic effect	84
AERP	84
Saline control	84
Adjusted Ki	84
pLADM	84
Tumors with CR	84
Antiviral index	84
Mean log concentration ratio	84
Deuterium retention	84
LogD5.0	84
Organ weight ratio	84
Delta P50	84
n50e	84
P50e / P50c	84
Content	84
Grip score	84
VCR accumulation	84
PCY	84
APD60	84
A0.5	84
fAUC/dose	84
logKb	84
Binding intensity	84
GID75	83
Transcriptional activation	83
Log 1/ED50	83
Food intake	83
p(1/MIC)	82
Velocity	82
Survival median	82
Compound remaining	82
Antagonistic activity	82
MLS	82
Optimal concentration	82
p24	82
RD50	82
Weight change at nadir	82
1/IC50	82
LED100	82
p nMED	81
ID (per g of tissue)	81
Partition ratio	81
CPM	81
Kt	81
SC200	81
VF	81
Clp	81
Toxicity Survivors	81
Delta IC	81
Min oral dose	81
Plasma selectivity	81
Differentiated cells	81
Amount of cross-linked protein	81
Modification of hemoglobin	81
Mean day of death	81
pNF	81
pCF	81
ID16	81
ID84	81
No. of animals responding/animals receiving drug	81
NOEC	81
AUEC	80
CF C20	80
FRP C20	80
Stereotypy score	80
Max delta BP	80
P50e/P50c	80
Relative activation	80
RTV	80
Log 1/ID75 (uM L-1)	80
Positive control	80
MIC=<80	80
Max inhibitory effect	80
MES ED50	80
Max intensity	79
No. of animals survived	79
CTL activity	79
log(1/ED80)	78
log10CCID50	78
B	78
Unaltered compound	78
Substrate activity	78
Tp	78
Lowest effective concentration	78
CCCT	78
AP50	78
rf50	78
Tt	78
Pleural fluid	78
ICD	78
Blockade	78
R.I	78
Plaque accum	78
Staining potential	78
Surviving factor	78
Serum Mg2+ level	78
Rate constant (k)	78
pAI50	78
Intrinsic efficacy	78
ID80	78
Rate of phosphorylation	78
log(IA)	78
BCM serum Ca	78
I 90	78
VAR	77
No. of shocks	77
TC25	77
Relative hydrolysis	77
delta Log P	77
cAMP accumulation	76
Acid output	76
Cellular uptake	76
Assembly	76
% NO2-	76
BP change	76
Growth zone	76
Max decrease in heart rate	76
Systemic effect	76
Vertebral blood flow	76
Vz	75
pAFC50	75
Uptake/Binding ratio	75
Erythema	75
Log K-1	75
Excess zone radius	75
GT rate	75
Average survival days	75
Log AC50	75
HSF	75
Relative tumor growth	75
Agonistic activity	75
E2 response	75
Actual duraction	75
Relative enzyme activity	75
Total tumors	75
Tumor number	75
Tumor mass	75
Relativity	75
Increase in dP/dTmax	75
Cytotoxiciy	75
No. of animals protected / no animals tested	75
Inhibition constant	75
pD	75
logKa	75
Log potency ratio	75
2-DG uptake stimulation	75
LD	74
KF	74
No. of positive animals	74
No. of rats	74
Hyperglycemic activity	74
Vasoconstriction effect	74
BNa	74
NBT positive cells	74
GMMIC	74
logMIC	73
RL	73
Vss	73
Treatment period	73
DR10	73
MTD50	73
Rblood_plasma	73
pDC50	73
deltalog10CFU/ml	72
CC30	72
Net accumulation	72
Verapamil index	72
EC50 iGC	72
apE	72
HSF release	72
Transport inhibition	72
Rel max	72
% turnover	72
kOH-	72
Reduction in RBS	72
Tritium release	72
Delta C urate / delta C insulin	72
Heart weight	72
No. of sensitive animals	72
% nucleotide present	72
2x PT	72
Cells killed	72
Crel	72
No. toxicity/tested	72
Ca2+ transport	72
Urinary glucose excretion	72
Drug responding	72
Log TA98	72
Cure	72
No. of axonal points	72
RCI	72
Suppression ratio	72
Astrocyte reversal	72
Mean score	72
Mean no. colonies	72
AH interval	72
Biodistribution ratio	72
Aggregation response	72
Survival increase	72
Tubulin polymerization ratio	72
nNOS activity	72
IG	72
AUCt/dose	72
Ae	72
Compound_Concentrati	72
Clast	71
logPF	71
Time constant T1	71
Time constant T2	71
Relative Ki	71
Total score	71
DNA crosslinking	71
deltaS	71
fEC50	71
Cr	71
MNTD90	70
Rate of hydrolysis	70
Increased life span	70
tR	70
Lowest effective dose	70
CT10 ratio	70
Change from Control (LV dp/dt)	70
max Delta Vmax	69
ST	69
ED6	69
ED delta5	69
ED delta20	69
MFED	69
No. of crosses	69
Influx Ki	69
RHA	69
Phosphorolysis	69
Increase in volume	69
Plasma-E2 concentration	69
Formation of erythema	69
pEC0.5,diss	69
Emax,diss	69
Palpha	69
pC2A	69
Max temperature decrease	69
S.I	69
DHP-I stability	69
TOX	69
No. of transfers	69
PKa	69
Max dose	69
UN	69
Control Uptake	69
Ca2+ current	68
Viscosity	68
Average lesion score	68
NADPH oxidation	68
LMA	68
KOX	68
E 1/2	68
log(Kinetic_solubility)	68
PI metabolism	68
% of selectivity	68
Inotropic effect	67
MRTlast	67
Change in entry latency	66
Physical dependence capacity	66
CV dose	66
Mean activity counts	66
k1	66
Gastric toxicity	66
Intestinal toxicity	66
IC200	66
Vrel	66
TOC ED50	66
bwc	66
Mean vesicle score	66
Cleavage rate	66
Thymidine uptake	66
T decrease	66
Log potency	66
IC>80	66
Epileptogenicity	66
C100	66
Minimal bacteriostatic concentration	66
Observed log APA	66
HV interval	66
Ca2+	66
Lactone production	66
pC60	66
Relative binding	66
KT	66
EC10x	66
Rel Max FI	66
Fraction cured	66
kOH	66
No. positive cases/tested	66
Change of CF	66
Change of CO	66
Change of HR	66
Change of SBP	66
Change of DBP	66
HVA control	66
AbsAC200_uM	66
MI50	65
Time constant T3	65
Concentration in serum	65
No. of mouse protected	65
MFC99	65
NADH oxidation	64
APD50	64
Pressure	64
Covalent binding	64
Phototoxicity	64
Optimal dosage	64
eLog D	64
Fraction ionised	64
Rotarod toxicity	64
Residual insulin secretion	64
Reverse transcriptase activity	64
Protected/tested	63
Range of death	63
No. of escape failures	63
ID/brain	63
Treated	63
Swimming activity	63
Remains	63
ID/g tissue	63
LH level	63
TGD	63
CR	63
POT	63
Log TA100	63
Total turns	63
KDs	63
HTD	63
Prejunctional agonist potency	63
Prejunctional antagonist potency	63
Postjunctional agonist potency	63
Postjunctional antagonist potency	63
BT	63
Survivor increase	63
MST increase	63
NEA	63
Retention ratio	63
Incidence of RBC decrease	63
Log MBC	63
Log K' IAM	63
Relative Kd	63
Tension	63
Urinary excretion	62
ED5	62
TWI	62
Serum triglyceride	62
Behavior	62
Tumor-free	62
RHR	62
SOD activity	62
Log 1/MIC (mM L-1)	62
Cell cycle	62
Decrease in Bmax	62
No. effective	61
2*APTT	61
BWL	61
Coronary flow	61
Change in cholesterol	61
Liver cholesterol	61
PD2	61
Total cells	61
Inverse relative potency	61
Thrombus weight	61
IC75	60
logGI50	60
Catalase rate	60
A	60
Nephrotoxicity	60
Drug level	60
Cytotoxic endpoint	60
QTc interval	60
MAPD90	60
Optical density	60
Recovered radioactivity	60
K50	60
FPG correction	60
Removal	60
ED (1mV)	60
C8h	60
-Log IC50	60
Photo-cross-linking of DNA	60
PI hydrolysis	60
Ca2+ transport S/M	60
Average onset	60
Decrease in RFU	60
increase in RFU	60
Log II50	60
Ip	60
Pw	60
Max contraction	60
Log Y	60
Survivors / total	60
ID99	60
Residual binding	60
p[BH+50]	60
Mortality inhibition	60
Highest active dose	60
Survivors at day 8	60
T-cell inhibition	60
Skin reaction	60
K rel	60
Log sweet/bitter	60
SSAT	60
Mean no. of shocks	60
Dec	60
Log KA	60
Exhibiting turning	60
Average turns	60
SF	60
Half duration	60
Increase in CBF	60
Iron excretion	60
Potency_Dyrk1a_uM	60
Vz/F	59
Cave	59
Log K delta	59
Spleen weight	59
Log 1/Km	59
Relative uterine weight	59
V1/2	58
New tumors	58
ER	58
DNA alkylation	58
Effectiveness	58
kin	58
pKi1-pKi2	58
No. of errors	58
Mean enhancement of binding	58
Decrease in IC50	58
AC200	58
MFC100	58
Glycaemia evolution	58
Body weight loss	58
Toxicity zone	58
PGE2 Level	58
Kd(app)	57
ED0	57
LC99.9	57
Occ50	57
GTP-gammaS index	57
Antiviral activity	57
pKinc	57
Binding competition	57
Change in blood flow	57
Combination_index	57
Tumor growth	57
Average seizure score	57
Duration of block	57
CV	57
IC50/IC50	57
PKC	57
Cation influx	57
Degree of resistance	57
Average inhibition	57
Liver TG	57
Horizontal activity	57
ERP1	57
ERP3	57
CT1	57
FOC	57
Survivors at day 15	57
Residual peptide	57
AUC Ratio	57
AUC cytotoxicity	57
Contractility	57
pTCD50	56
ZImax/KZI	56
Time constant T4	56
APD90	56
Accumulation counts	56
No. of tumours	56
No. of cultures active/total	56
pKred	56
Arrhythmias times	56
Parent compound	56
Growth of cells	56
MNTC	55
IC50/[E]	55
E1/2	55
Ileal activity	55
Selectivity ratio S3/1	55
Saluretic score	55
log Kp	55
Challenge time	55
NOHA	55
PC95	54
AUMC	54
log(10'6/IC50)	54
pTD50	54
Rate of decrease	54
Vm	54
CE37	54
Ulcer index	54
Jump latency time	54
Initial rate ratio	54
GI50 ratio	54
TGI ratio	54
LC50 ratio	54
SD50	54
Differential affinity	54
Remaining rate	54
Activity B	54
MTX equivalent	54
Km/Kcat	54
N/A	54
Muscarinic receptor affinity	54
Mean day appearance of lesions	54
MTS	54
GSH level (mg)	54
Log beta3	54
Delta F75	54
K eff	54
Cross linking	54
Cell size	54
Cell no	54
Hill slope	54
Cardio selectivity	54
Metabolic turnover	54
BW loss	54
Min antiviral concentration	54
Stomach	54
Dissociation ratio	54
FR	54
Change in conflict	54
Polyamine pools	54
Fold_activity	54
Thymolysis	54
Difference	54
MRP	54
CT3	54
Net dry weight	54
Dead	54
Survival treated	54
Extremes treated	54
Controls	54
QT	54
Insulin secretion	54
Colony formation	54
Excreted	54
Thyroid status	54
Change in WBC	54
MF	54
Muscarinic agonist index	54
Myoblasts with parasites	54
Survival after 10 days	54
Volume of ascrit fluid	54
ascrit	54
ODC	54
AdoMetDC	54
No. of pos rxns	54
Log Kobs	54
T-C/C	54
Positive cells	54
alphaKi	54
MABP change	54
Injection dose/g	54
Min lytic concentration	54
ICmax	53
Alpha	53
k3	53
Kon	53
pKi ratio	53
ABC	53
CGI	53
Maximal effect	53
CS index	53
Total binding	52
Beats/min	52
Epidermal thickness	52
Mice	52
Speed of performance	52
Body temp change	52
Antibiotic resistance	52
Alpha-cholesterol	52
pC25	52
Alpha-adrenolytic activity	52
Ca2+ antagonism	52
Day of first positve reaction	52
DLS Concentration	52
Kif	52
tox/total	52
Natriuretic activity	52
Kaliuretic activity	52
Potency_Clk3_uM	52
KD50	51
GR20	51
Virucidal	51
Day 9-RTV	51
Day 22-T/C	51
Tonic seizures	51
G-protein activation	51
GABA current	51
Average score	51
ToxD/Surv	51
AD	51
QT interval	51
ODC activity	51
Vmax / Kmax100	51
Max cAMP	51
Ccellular	51
Synergy EC50	51
Load	51
30 days survivors	51
Mean response/min	51
Cr release	51
Activity remaining	51
Thromboxane B2 (TxB2)	51
Sterilized	51
Log Pe,max	51
Log Po	51
Increase in dP/dt max	51
MET	51
Hydrophobicity index	51
Relative daunomycin accumulation	51
LDL oxidation	51
EA	51
Fraction of accumulated 86Rb remaining.	51
Tumor burden	51
Antihypertensive score	51
Treated cells	51
Log ESA	51
logCL	50
Vc	50
EC5	50
Substrate specificity	50
K'	50
Cytotoxic activity	50
PR	50
-Log K	50
KD'	50
Mean log GI50	50
Mean life extension	50
T/C untreated	50
IC2x	50
S0.5	50
Avg IC90	50
GT fold stimulation	50
Biological evaluation	50
NR	49
Blood urea nitrogen	49
Max tolerated dose	49
FE	49
LDH release	49
Kd1	49
Cage leaving	49
K H	49
Pigment binding	49
In/Fi	49
Seizure score	49
log1/S0	49
LC60	48
MFC>99	48
Relative intrinsic activity	48
Inotropic potency	48
Effect on polyamine pools	48
Infarct	48
Normal	48
Inflamed	48
Analgesic	48
Probability	48
Reduction in movement	48
pK3	48
Dose/ml	48
No. of canine	48
Rate of reduction	48
Binding inhibition	48
Inactivation time	48
Relative esterase susceptibility	48
Survivors at day 30	48
Time to max. inhibition	48
Decrease in MAP	48
ECAUC0.2	48
TVI	48
Acute tolerability	48
Serum metabolite	48
Amount delivered	48
ILB	48
Log KH	48
Log KL	48
Ca2+ reduction	48
Activity (mg)	48
No. of lung metastasis	48
Dependency	48
A0	48
MED10	48
KiAH	48
HF ratio	48
Log t1/2	48
Carbohydrate	48
Median survival	48
Peak deltaMAP	48
Peak deltaHR	48
Increase in dP/dtmax	48
Decrease in the QA interval	48
FC50	48
Reduction in virus titer	48
Cell protein in untreated control	48
Colony_count	48
Spreading	48
ER max	48
Specific Displacement	48
Change in IC50	48
Apoptosis index	48
Radioactive constituents	48
pA2 - pA10	48
T/C 41	48
T/C-CQ	48
Cardiac depression	48
Change systolic BP	48
pKact	48
Oncostatic index	48
Ref I oncostatic index	48
Kin x10e3	48
Electrolyte excretion	48
Rs	48
IA50	48
EC75	48
Glucose rise	48
Log Pn	48
PWT	48
AIDH activity	48
Femoral blood flow	48
Delta latency time	48
log10FFU	48
Total counts	47
PG	47
Change from control	47
DHP-I susceptibility	47
Alphax10E	47
Tlag	46
logKA	46
C20 FRP	46
Partial remission	46
Dose range	46
Glucose	46
MED90	46
Ionization	46
CLT50	46
[Ca2+] variation	46
Hydrogen peroxide degradation	46
FPT	46
FBP	46
Change of body temperature	46
median survival time, days	46
LM	46
Active/total cultures	46
Relative uptake	46
Frequency	46
Mean hemagglutination titers	46
Dose interval	46
Anesthesia duration	46
Vc/F	45
log(1/CON)	45
T/C 1.2	45
Communicating cells	45
Delta HDL-C	45
pAD	45
Vasodilatory rate	45
Mineral apposition rate	45
cpm	45
RVR ED15	45
Decrease RVR	45
T/C survival days	45
Resting potential	45
Change in rat blood sugar	45
Cell permeation	45
T/C (ratio of treated to control)	45
RMP	45
3H-TdR incorpolation	45
Hemispheres reduction	45
Scavenging activity	45
Weight changes	45
CMax	45
Hx shift	45
Vm/Km	45
Decrease in fighting	45
No. of living cells	45
Alkylation	45
B50	45
k''	45
VCT	45
Log K'W	45
Animals cured	45
Total lysis	45
OD(540nm)	45
Survivors / treated	45
ID95	44
Amount bound	44
Delta heart rate	44
Effective molarity	44
Eggs	44
TGI correlation coefficient	44
k2'	44
PDE inhibition	44
Paw weight increase	44
Edema inhibition	44
Log 1/conc (mM min-1 L-1)	44
Log 1/D125 (L1210) (mM kg-1)	44
Ulcer score	44
GSH-Px activity	44
TAC	44
Reversal type	44
pKd	43
LBF	43
Kd2	43
K diss	43
Tumor uptake	43
Antilipid peroxidation	43
LD95	42
I75	42
log(1/LC50)	42
IC60	42
IT50	42
T>MIC	42
Daq	42
Average latency	42
Amine formed	42
Serum stability	42
Edema density	42
Hypocotyl length	42
No. of dogs used	42
No. of dogs reverted	42
Ouabain	42
Duration of reversal	42
Nitric oxide	42
Peroxidase rate	42
Clonic seizures	42
GSTCP activity	42
No. of mice dead/day died	42
Peak time	42
No. of plaques	42
Increase over control	42
Hypotensive activity	42
-Log Sw	42
Adduct formation	42
Kidney weight	42
Log K2	42
Relative bioavailability	42
Ko	42
Abdominal fat	42
ED3	42
30 day survivors	42
Plasma histamine	42
Photosensitization	42
KDMPC	42
Urine osmolality	42
Stain index	42
No. of writhings	42
Decrease in mean arterial pressure	42
Free complex	42
Control relaxation	42
Increase in blood pressure (P/R)	42
POT vigilance	42
EI	42
KI'	42
C/P	42
Prolactin control	42
Prolactin treatment	42
VM	42
Histopathology	42
Positive	42
Oxidation rate	42
No. protected/ No.dosed	42
Growth delay (T-C/C)	42
Tonic-clonic seizure	42
Max decrease in blood pressure	42
Adjuvant effect	42
Worm reduction	42
Toxicity related death	42
Inhibition potency T/II	42
Analgesic effect	42
Pcaco2	42
K NBP	42
RT	42
GOT Level	42
GPT Level	42
ALP Level	42
Bilurubin Level	42
Average body weight change	42
Anticonvulsant dose	42
d tox	42
Picoequivalents of amine/10e6 cells	42
AI recovery time	42
Log 1/D125 (mM kg-1)	42
Delta pEC50	42
Potency index	42
Precursor inhibition	42
Ratio GI50/EC50	42
Max collateral index	42
Collateral index	42
NG ratio	42
Max hypotension	42
Log M	42
Least dose	42
Log 1/ID50	42
Log delta (1/T2)	42
K calc	42
Initial average tumor weight	42
Final average tumor weight	42
logEC50	41
MDR	41
Relapses	41
pLADm	41
MCT	41
MfI	41
I0.5	41
Ionotropic activity	41
-Log IC25	41
ED125	41
Kbapp	40
EC12	40
KiH	40
pKm	40
Concentration ratio	40
Cell kill	40
NM	40
KD app	40
A/B ratio	40
-Log EC20	40
Mean RBF	40
Mean LAF	40
Mean HR	40
-ln K	40
Survivors alive/total	40
MP	40
Fluorescence Intensity	40
P50d/P50c	40
Average No. of metastasis	40
No. of mice effected/No. of treated	40
Cardiac frequency	40
Respiratory frequency	40
PDI	39
Shutdown time	39
Delta ED50	39
SB	39
Tumor inhibition ratio	39
Oral duration	39
Radioligand bound	39
Urine/bile	39
DNA single strand breaks	39
RD1000	39
Necrosis response	39
Regression response	39
Plasma cholesterol	39
Weight change on day 5	39
Log tumor cell kill	39
Drug deaths	39
Body weight loss at nadir	39
Ki/(Km/Kcat)	39
Cells arrested	39
Reduction in virus yield	39
MTX ratio	39
VOLSYN	39
K OX	39
K HOX	39
Vascular relaxation	39
Max SBP	39
ICL50	39
DNA fragmentation	39
Change in temparature	39
Logit_p(conc)	39
Differentiation activity ratio	39
ED37	39
DNA damage	39
Mutation frequency	39
ln Kt	39
ln Kp	39
increase in response	39
Protective Index	39
Photolysis	39
Enhancement ratio	39
MED100	39
Behavioral response	39
Med tumor weight	39
Phagocytosis	39
ERP observations	39
CLz/F	39
P24 concentration	39
LD80	38
Histone_modification	38
AUC p	38
AUC c	38
Duration time	38
Pressor activity	38
Max aggregation response	38
pLADy	38
Change in systolic BP	38
K+ Ion content	38
Na+ ion content	38
K+/Na+ ratio	38
Corr	38
Cmax_[GH]	38
Approx. lethal dose	38
Change MAP	38
Selectivity ratio S3/2	38
DAP	38
Residual contractile activity	38
CIC	38
1/kobsd-ka	38
[EOP']infinity/[EOH]infinity	38
Ca2+ elevation	38
RT50	37
VT50	37
HD100	37
Bleeding time	37
Accumulated counts/30 min	37
Onset of action	37
Peak concentration	37
Max agonist response	37
Mean tumor volume	37
Tail vein toxicity	37
VFT	37
Ca2+ flux	37
Symptoms	37
NSB	37
BSI	37
FaFg	37
No. of animals exhibiting toxicity / Number of animals tested	37
Delta mV	37
AUDPC	36
pSI	36
Cp(T)	36
Log Ka	36
Log Pmw	36
Testosterone	36
LH	36
Plasma levels	36
FIC index	36
GPI	36
RAP	36
TVR	36
Weight gain or loss	36
Tumor/blood ratio	36
Tumor/liver ratio	36
K app x10e-7	36
Glucose correction	36
GPGB tension	36
Unchanged tracer	36
Time in flight	36
MES/TEST	36
TOX/TEST	36
Fecal recovery	36
VI30	36
log S	36
Falling	36
Transacylation rate	36
Brain penetration index	36
av	36
Cell cycle fraction	36
lesions	36
MDL	36
QTc delta	36
ERP (delta)	36
HR(delta)	36
mBP(delta)	36
LV dP/dTmax(delta)	36
CA activity	36
Peak current	36
Extraction	36
C5a max	36
Dopamine level	36
Log geometric mean	36
Urinary level	36
DNA photo-crosslinking	36
Logit bioavailability	36
Log Phep	36
Plasma corticosterone	36
Platelet count	36
Urine	36
Intensity of erythemia	36
T1/2 increase	36
K-1 decrease	36
[3H] TdR uptake	36
Log [-8]	36
Log [-7]	36
Log [-6]	36
Log [-5]	36
Protonated	36
SC	36
Potencymean	36
pKapy	36
pKabz	36
Log k'o	36
HbS solubilized	36
Catalyptic action	36
Ibuprofen	36
Kb app	36
O2 production	36
LH concentration	36
Activity remaning	36
L-T3	36
ME increase	36
Myristoylpeptide	36
kinact/Ki	36
Potency vs EKC	36
Protective activity	36
Mortality range	36
Fluoroscence	36
Total	36
Formaldehyde	36
Acetaldehyde	36
RPP	36
Cholestrol levels	36
ASAT levels	36
ALAT levels	36
Control response	36
Edema ratio	36
Serum corticosterone	36
pK1a	36
pK1b	36
pK1d	36
Parasites	36
Log Pc18	36
Log 1/LD50 (mM kg-1)	36
Mean survival in days	36
-log(1/EC50)	36
SF50	36
MBC99.99	36
Ea	36
Incorporation rate	36
RBA ratio	36
Radioactivity level	36
Uptake at C50	36
Cure rate	36
Prodrug reduction	36
Antiemetic activity	36
Gastric emptying	36
Relative ODN uptake	36
Mean no. of lung colonies	36
log1/activity	36
IT100	35
PFU/ml	35
BEI	35
ED60	35
MRD	35
Cellular reversion	35
IC85	35
Log 1/ED40	35
AC10	35
AbsAC0.39_uM	35
AQ	34
Alkylating activity	34
Complete remission	34
RTP	34
Log change	34
Emesis	34
Mean IC70	34
E50	34
TC lowering	34
DNA cleavage activity	34
Phosphorylation rate	34
Ki low	34
Relative maximum	34
GSH	34
Log k' w	34
Kill at C50	34
Log KAT	34
Cells in metaphase	34
Passivity	34
Reflex	34
Antipapilloma activity	34
Toxicity day survivors	34
No. of mice alive	33
M.A.D	33
Mean volume of hind paws	33
Inflammation units	33
Arthritis scores	33
KT4	33
KPCB	33
Apoptotic index	33
cAMP	33
Rotorod	33
Lesion frequency	33
DTH	33
Triglyceride correction	33
Atttacks	33
Mice with lesions	33
S/T	33
Change in TC	33
FR10 treated	33
FR10 control	33
SBP change	33
OD max	33
[EA]	33
[A]	33
Pe	33
Translation	33
Lag time	33
Max.stimulation	33
General activity	33
Increase in HR	33
CO	33
Change of size	33
Log 1/Kd	33
Delta Ca	33
Log 1/delta/Ca	33
Efflux	33
Onset of block	33
Drug period	33
Mean rate constant	33
K x10e-5	33
Exclusion parameter	33
Relative rate metabolism	33
Control period	33
Ca2+ binding protein	33
Relative agonist activity	33
2x TT	33
Log 1/ISA	33
G Index	33
Max relaxation	33
Relative phosphorylation	33
Protein interaction energy	33
No. of dead animals	33
D/P	33
Phosphor	33
7-day weight change	33
Dose per organ	33
Delta mmHg	33
Selectivity coefficient	33
inhibition of control	33
IW	33
IM	33
No of monkeys	33
Functional profile	33
Max lowering	33
Macrophage cytotoxicity	33
Maximum test concentration that did not exhibit cytotoxicity	33
Phospholipidosis as % of positive control	33
HIA	33
Kact	32
gammaCMC	32
pGC50	32
CQ	32
Counts	32
Counts/30 min	32
Relative t1/2	32
Of control	32
Tensile strength	32
Relative value	32
Stretches	32
PEI	32
Apoptotic activity	32
Original amplitude	32
TGI50	32
Immobility	32
Cl-	32
Cytostatic activity	32
-Log MIC	32
AUClast/dose	32
MIC>80	32
RLU/well	32
Log B/F	32
Log 1/IC50	32
Gated current	32
CT-luci TAR	32
CTS increase	32
AI	31
Progressed tumors	31
SEC50	31
Relative inhibitory activity	31
No. of entries	31
RBI	31
Tubulin polymerization	31
Tumor cure	31
CAC	31
No. of nonpregnant/treated	31
-Log activity	31
Urinary output	31
Spont activity	31
Tail flick latency	31
pEC15	31
c30	31
c90	31
CTP	30
Rice stem length	30
DNA unwinding concentration	30
Max delta MABP	30
Horizontal screen	30
Induced convulsion	30
Triglyceride level	30
Delta RBF	30
Writhes	30
Log sensitivity	30
clogP-logP	30
cAMP increase	30
Relative influx	30
GMS activity	30
Efflux Ki	30
No. of tumors/mouse	30
Inhibition type	30
Active/total	30
MAC reduction	30
Concentration_Plasma	30
Gastric lesion score	30
Phosphorylating activity	30
Relative substrate velocity	30
Animals affected	30
Log P16	30
BAT weight	30
cKi	30
Cell toxicity	30
Cytochrome loss	30
Carboxylase activity	30
M-agonist index	30
Catalepsy score	30
Rate of oxidation	30
Log TCID50/mg	30
Distribution percent	30
Transacetylation rate	30
k/K	30
Max vasoconstriction	30
EC99.9	30
Mean inhibition	30
Relative seminal vesicle weight	30
Perturbations	30
Kid	30
Incidence_count	30
rb	30
Highest nontoxic dose	30
Bmax1	30
R/S ratio	30
Mean value	30
CPM x1000	30
Mean effect	30
Growth rate	30
60-day survivors	30
Delta LV	30
Delta coronary flow	30
Tumor half growth	30
Mean increased life span	30
Induction number	30
Iron clearence	30
ID25	30
MyristoylCoA	30
K12	30
K21	30
K13+K23	30
Max delta FC	30
Analgesic efficacy compared to morphine	30
Analgesic efficacy compared to epibatidine	30
Substrate	30
Clonazepam	30
Serum total cholesterol	30
Alpha-lipoprotein cholesterol	30
Oxygen uptake	30
Inhibitory potential	30
Metabolic rate	30
Mice In. / Fi.	30
Body weight In. / Fi.	30
-Log alpha	30
Ctt2	30
Initial mean arterial pressure	30
Max reduction in mean arterial pressure	30
Inhibition effect	30
GTPase Activity	30
IAR	30
NTD	30
Dose elevation	30
Max MBP	30
Relative differentiating activity	30
Area	30
-Log I50	30
Fresh weight	30
Log concentration	30
Log 1/B+100	30
Log 1/Th+200	30
Log 1/B.5	30
Log 1/B+1	30
Count/h	30
Log 1/EC50	30
MSIC	30
Residual secretion	30
Ki50	30
Symptom initiation	30
Animal death	30
Median	29
TTO	29
Pressor response	29
APA	29
Max increase in coronary flow	29
Chlorine uptake	29
Relative florescence	29
Carbonyl group	29
Gain	29
Top1 cleavage activity	29
Actvity	29
Delta BP	29
VDR affinity	29
LOAEL	29
AUCED90	29
Average peak Concn.	29
Fluorescence intensity	29
EC1000	28
K-1	28
Unbound	28
Glucose uptake	28
ATP content	28
Static tumors	28
Log K3	28
G2/M	28
T/C corr	28
Fold shift	28
Tumor growth delay	28
k cat/Kuncat	28
Radiation equivalent	28
Hind-paw lick latency time	28
Net grain counts	28
Experimental DPM	28
LWI	28
dose BP/BP	28
Relative level	28
CMI	28
Myoblast with parasites	28
Parasites no. per 100 Myoblasts	28
Ulcerogenic activity	28
NLCK	28
Equilibrium OD340	28
No. of males cohabited	28
No. of males mated	28
No. of males fertile	28
Ulceration	28
Increase in DPM	28
Erythema induction	28
Pigmentation capacity	28
Cmax normalised	28
AUC normalised	28
MBC=>99	28
Log CFU	28
Cat score	28
Aggregates	28
Flow rate	28
Therapeutic effect	28
Log rate constant	28
5-HT syndrome	28
Mean decrease	28
Mean duration	28
Survivors at 24 h	28
Plasma ALT at 24 h	28
pMLD	27
MTS50	27
TC90	27
Prodrug remains	27
Kinase activity	27
Min ED	27
khydr	27
I / E100	27
HDL-C change	27
PKB	27
Na+ restoration	27
Acute TI	27
Chronic TI	27
Derived trabecular thickness	27
Derived trabecular number	27
Directly measured thickness	27
Connectivity density	27
Trabecular thickness	27
Trabecular no.	27
Tissue area	27
Marrow area	27
Endosteal mineralizing surface	27
Endosteal eroded surface	27
Periosteal mineralizing surface	27
Periosteal mineral apposition rate	27
Mortality number	27
Hormonal activity	27
pKa5	27
No. of strains	27
Fold reduction	27
Therapeutic efficacy	27
Onset seizure	27
Acid secretion	27
Fold_reduction	27
Range of deaths	27
Maxi-K current	27
Infection score	27
LDL	27
HDL	27
Challenge dose	27
DC	27
Lysis time	27
First adverse effect	27
Plasma half life	27
Log GTI	27
Toxic/total	27
NOEL	27
PDR	27
Pt	27
Urine output	27
Na+ output	27
K+ output	27
PT extension	27
Inhibition (at concentration M)	27
COF	27
Eicosanoid production	27
Antiamnesic activity	27
Anticonflict activity	27
Maximal binding	27
Summation MABP	27
Max binding	27
T2	27
Corpora lutea	27
Implants	27
No. pregnant/mated	27
Pregnant	27
Range of survival	27
Primary response	27
Secondary response	27
TAI	27
Animals dead	27
AHV	27
K A	27
Responders	27
Ca2+ serum	27
Log ratio	27
PRL	27
DA utilization	27
Unwinding	27
Mean change	27
Relative thymus weight	27
Relative adrenal weight	27
Amplitude	27
APD70	27
Na+ inactivation	27
Tumor free survivors	27
DSB	27
Permeated	27
No. of mice surviving >6 months	27
Max change	27
Log PI	27
Cpss	27
kn	27
Total turnings	27
Long-term survivors	27
dp/dt	27
Monoamine level	27
Dopamine release	27
log1/GI50	27
pEC170	26
log10LT50	26
MNTD50	26
Cp max	26
ClC95	26
B/P	26
Relative intensity	26
Koff	26
Infarct volume	26
Prolongation	26
Med tumor area	26
Observed at	26
Ki slope	26
Ki int	26
Spontaneous motor activity	26
Exploratory activity	26
KDNB	26
Total acid output	26
RSA tR	26
Blockade duration	26
Vagal response	26
Lesion_Clearance	26
DNA relaxation	26
Ventricular rate	26
Etopic beats	26
Sp St	26
Sinus beats	26
EC125	26
GHmax	26
[GSH]	26
Uterine activity	26
TPI	26
Min concentration	26
Hepatic necrosis in survivors	26
pBBB	25
Intrinsic_solubility	25
Onset time	25
Keq	25
RVmax	25
AHA	25
T/A	25
Cumulative dose	25
MIC75	25
GI25	25
Drug response	25
Rate response	25
Fold selective	25
Injected (dose/g)	25
Protected/Tested	25
Intinsic activity	25
Log LD50	25
molecular ellipticity	24
DT50	24
GR10	24
MAT	24
KiL	24
logPm	24
No. of killed or paralyzed	24
Diffusion analysis	24
K6	24
Atherogenic index	24
Chemotactic index	24
HCMV yield	24
Deiodination	24
Vocalization time	24
Quenching	24
Relative Potency Ratio	24
Counts/30	24
Tissue swelling	24
Change in MABP	24
Change in LV dp/dt	24
I80	24
Blood clearance	24
K3	24
Log TCI	24
Extension	24
Max weight loss	24
Delta I/I	24
BW	24
Log effect	24
Reduction in AUC	24
Reduction in TG	24
tRNA peak exclusion	24
Normal weight gain	24
Delta mean blood pressure	24
Mean response	24
Amount incorporated	24
Log K'w	24
Log cfu/g of tissue	24
Supressive effect	24
G0/G1	24
GTP-gammaS Index	24
Tolerance	24
Tissue level	24
K app ratio	24
Delta F	24
pEMR	24
[Ca2+] increase	24
Ki.c	24
Of non-HDL-C	24
Of HDL-C	24
max inhibition	24
Cocaine	24
Weight at term	24
Microsomal stability	24
Bmax2	24
Consumption	24
Cholesterol level	24
Receptor occupied	24
cholesterol level	24
Lipoprotein level	24
Enantiomeric composition	24
Max lowering MABP	24
Property	24
Contractility (LV dP/dt)	24
Reserpine hypothermia	24
Dose modification	24
LD app	24
Hyperactivity	24
Wet weight	24
Slow binding	24
GDPactivity	24
No. of protected/tested	24
Diazepam antagonism	24
k x10e-3	24
NADH oxidized	24
Hypermotility	24
Anticonulsant activity	24
Ke naloxone	24
Antitumour activity	24
Apparent binding constant	24
NSVT	24
Plasma	24
R+V	24
rT3 Production	24
Conversion dose	24
Activity MABP	24
AAL	24
IC0	24
NSR survival rate	24
UB	24
Relative binding potency	24
Regiospecificity	24
Adjuvant activity	24
PL-017 shift	24
MAO deamination	24
Vasodilation	24
Average colony count	24
Macrophage activation	24
Complete spontaneous reversal	24
Neostigmine reversal	24
Degranulating activity	24
Average activity	24
Mean day of death for total dead	24
k2''	24
Relative inhibitor potency	24
Khydrol	24
K alkyl	24
Enzyme inhibition	24
Maximal activation	24
Fold change	24
ED75	24
deltapKi	24
No. resp animals / Total	24
Rate max	24
K'a	24
MG-MID	24
-Log concentration	24
GSH level	24
No. of deaths/mice injected	24
No. of mice receovered	24
Max release	24
SBP decrease	24
Average weight gain	24
Threshold active dose	24
K obs / 1 1/Ms	24
Urine Na+	24
Urine K+	24
Change in cell number	24
Relative effect	24
Serum TG	24
Bronchoalveolar lavages	24
No. of pits	24
Calculated Ratio	24
Kina	23
V/K	23
No. of axonal branch points/cell	23
krel	23
P value	23
Delta RM	23
ED50 Ratio	23
S50	23
AUCmet/AUCp	23
EC60	23
Cell survived	23
PMA	23
Max IOP reduction	23
2DG uptake	23
Stabilty	23
AbsAC0.54_uM	23
Kcat(app)	22
Occ90	22
Thermogenesis	22
TPR	22
Cardiac output	22
Tumor area	22
MID log LC50	22
Relative ionotropic activity	22
Blood AcH	22
Change in No. of trophozoites x 10E-5	22
Distribution ratio	22
CA	22
Decrease in heart rate	22
MED99	22
No. of rats with 5-HT syndrome	22
Psychotropic Effect	22
Max suppression	22
Hgb levels	22
T1/29	22
No. of implants/pregnancy	22
Resorbing implants	22
Diuresis	22
% of control	22
NSR	22
E max	22
Cytocidal activity	22
TD100	22
MDL50	22
Increase in plasma amylase	22
Ke ratio	22
X1(50)	22
Log APA	22
FBF	22
pKa,1	22
pKa,2	22
Degradation ratio	22
KIs	22
pEC200	22
BC	21
LC20	21
Vbeta	21
fCmin	21
logC50	21
CIC90	21
Iron mobilized	21
DTT inhibition	21
C/T	21
HCMV yield reduction	21
k act	21
Acceleration	21
Plasma glucose level	21
Relative liver weight	21
Inhibitory ratio	21
Damaged area	21
Saftey margin	21
Amount formed	21
Parasite_Clearance_time	21
T.I.	21
Lactate produced	21
Average survived	21
Irreversible binding	21
pEC20	21
CNS activity	21
Spontaneous activity	21
ILS40	21
Resowing	21
Incidence of occlusion	21
Vomiting frequency	21
Max contractile force	21
DNA peak exclusion	21
Relative rate of decomposition	21
CBF-ID75	21
Incorporated	21
Repolarization time	21
Lambda-ex	21
Lambda-em	21
Cell saturation	21
Intrinsic vasorelaxation	21
Max Uosm	21
ID30	21
LLR msad	21
Induced frequency	21
MED99.9	21
Kun	21
Spread	21
Delta I	21
Log net cell kill	21
NO2- (mol/mol)	21
Lesion index	21
D2 duration	21
Antibody titer	21
Time to onset	21
Time to offset	21
IE1	21
Log 1/ED30	21
Receptor binding	21
Oxygen consumption rate	21
E0	21
Proconvulsant action	21
T3	21
Platelet	21
Group toxicity	21
GABA agonism	21
Oxygen consumed	21
Duration of immobility	21
PFC/spleen	21
DBP-20	21
2x TG	21
Specific radioactivity	21
Anti-infectious effect	21
Mitogenic effect	21
Pyrogenic effect	21
LAL test	21
Avoidance time	21
Saq	21
pCB50	21
Oxytocic activity	21
Block time	21
pKHB	21
Dose (urinary recovery)	21
Change HDL -C	21
Change non HDL-C	21
SPF	21
UVAPF	21
-log(solubility)	21
Absolute turn angular/3 min	21
Creatinine	21
GII50	21
Serum lipoprotein cholesterol	21
Control value	21
Testes weight	21
Average change in weight	21
Average survival time	21
MCD	20
CD100	20
BBC	20
pA2-pA10	20
Max efficacy	20
Occlusions	20
Concentration of max response	20
D-2	20
Infected erythrocytes	20
Transactivation	20
Conc_plasma	20
Function	20
Glucuronidation rate	20
k2c	20
Relative ability	20
K Bapp	20
% binding	20
Cytoplasmic vacuolization	20
Substrate metabolized at 1hr	20
Degree of activation	20
Gellar cook activity	20
Log k GSH (s-1)	20
lnK	20
Log 1/GI50	20
A/Ad	20
Dose/g tissue	20
C10 N2	20
Intrinsic actvity	20
Control growth	20
Low	20
Amount of metabolite	20
Turns/first hour	20
Urinary Na+	20
Change in cAMP	20
CTF	20
Vss/F	20
%AUCextra	20
DP	20
TP	20
Serum LDL-cholesterol	20
Serum HDL-cholesterol	20
Complex_formation	20
TBPS IC50	20
I/C	20
CFC20	20
Water consumption	20
Dead/total	20
Hemodynamic change	20
Post drug blood pressure	20
PKa1	20
PKa2	20
pI	20
Z	20
Mean graft survival	20
k'/k'+1	20
HMGR activity	20
Min lethal dose	20
BBC50	20
R50	20
ABBC	19
GFR	19
Transport	19
Severity	19
k-1	19
Agonist effect	19
Ip score	19
Subcut score	19
Renal clearance	19
Osmolality	19
Max fall in MAP	19
ke	19
ClT	19
Skin uptake	19
Antagonist effect	19
Binding stoichiometry	19
Log CDQR	19
Log CDGH	19
AUMCt	19
Ki high	19
No. of metastases	19
ED70	19
Tested/Control	19
Max hemorrhage	19
CT2	19
No. total	19
%PFU	18
Cmax_unbound	18
OMNI med	18
TPO(max)	18
Fungicidal concentration	18
Rat fertility	18
Relative Km	18
Log beta	18
Relative response	18
Static remission	18
Cell no./dish x10E5	18
Cell no./dish x10E3	18
MHPG_SO4	18
Inhibitory activity ratio	18
Log TGI	18
Change in FVR	18
Change in TPR	18
Log 10 cell kill	18
Peak radioactivity in blood	18
Na+ ratio	18
Latency to exit	18
Topoisomerase-I activity	18
K Tm	18
M2/M1 index	18
Agonist index	18
Change in MAP	18
Virus titer	18
Thr uptake	18
pA1	18
Log Palk	18
Residual RR activity	18
Cells positive	18
Cell	18
Exploration motility	18
Basis motility	18
Threshold current	18
No. of spikes	18
Fibers/preparations	18
Alpha 50	18
EMax	18
Pancreatic response	18
Kc	18
k+2	18
k+2/k	18
Change in sensitivity	18
Activity (umol/g.of liver 75.min)	18
SR	18
Hexobarb ST	18
Antagonism effects	18
Change of hemoconcentration	18
mequiv of HCl	18
Reverse potential	18
k-1 app	18
Relative dissociation rate	18
ILC	18
PCoct	18
Egg reduction	18
Eudismic ratio	18
FACO Activity	18
CLm	18
Reversibility	18
Depletion	18
KCS, APP	18
CAI activity	18
Approximate colony formation unit	18
U osm	18
Mean activity	18
CBF increasing activity	18
P ratio	18
Midpoint dose	18
pC20	18
Activity regained	18
FPTase activity	18
SNA	18
Spermidine concentration	18
cpm/million cells	18
Fallen/treated	18
No. of writhes	18
Max platelet response	18
Max respose	18
K+2	18
K+2/Ki	18
Temperature decrease	18
EC5x	18
GABA enhancement	18
Glycine antagonism	18
Drug mol/base pair	18
Antinociception	18
Log MrI	18
COI	18
Denaturation rate constant	18
pD2 app	18
Time of licking	18
MSC	18
Synergy with methicillin	18
Neurite bearing cells/total cells	18
NED	18
VLDL	18
DMF	18
Avoidance response	18
Onset for sleep	18
Thymidylate shift	18
Cellular content	18
PRCF	18
3D PSA	18
ks	18
Max dV/dt	18
Developed tension	18
Max uterine weight	18
Propioaldehyde generated	18
k cat/Ki	18
2x aPPT	18
TE50	18
Mu/delta ratio	18
Acetylcholine level	18
Decrease in pressure	18
Sensitisation	18
Amylase stimulation	18
C10 air	18
Max rev	18
Vagus	18
Cells sickled	18
Social interaction	18
CE logK'	18
Nature	18
AUC metabolite/AUC radiolabel	18
Selective toxicity	18
Relative molar potency	18
Q1/2	18
DT	18
Dmax	18
Initial_rate	18
Imbalance	18
GOF	18
Hemolytic activity	18
Uncut DNA	18
CT5	18
IE	18
Succeeded/tested	18
Histamine level	18
Acc. counts	18
Hypnosis duration	18
Total peripheral resistance	18
Peak effect	18
No. of ferrets	18
Control death day	18
Control tumor volume	18
Reduction of heart rate	18
Hypotension	18
Ratio Cmax	18
Cp/dose	17
AUBC	17
influx_CL	17
efflux_CL	17
XL50	17
Offset time	17
Agonist	17
Plasma clearance	17
Change of weight	17
BPI	17
Delta logS	17
T/C max	17
Binding selectivity	17
Relative lipophilicity	17
Pigment induction	17
Aberrant cells	17
VmaxH	17
KmH	17
Vdss/F	17
MLC50	17
pCD	17
Ep	17
Rats blocked	17
Fungicidal	16
logKd	16
Resistance reversal	16
LSD	16
Cmedia	16
Diffusion	16
Max fall	16
IC50 reduction	16
Selectivity rating	16
I/E	16
Log PTA	16
DW	16
Dobs	16
Fever response	16
MPD	16
K-2	16
Control of P-450 marker	16
Adrenochrome formation	16
Oligo modified	16
Oligo shifted	16
Average proportion	16
Proportion of survivors	16
Human potency	16
Cysteine reaction	16
Morphology	16
I/IC50	16
Latency to step through	16
CAT activity	16
Delta K	16
Delta FFA	16
No. of pits/slice	16
Mean pit size	16
Mean total resorption	16
-ln (MIC)	16
Basal control	16
Papp e-6	16
Uterotrophic activity	16
Antiuterotrophic activity	16
Rate of hydride transfer	16
TPO	16
Revertant colonies per plate	16
Uptake selectivity	16
Flaking score	16
Abrasion score	16
Cutaneous toxicology score	16
Max blood pressure fall	16
Inhibitory effect	16
Gastric concentration	16
Remaining ratio	16
E/Eref	16
VRT	16
KDss	16
HD10	16
No. deaths/treated	16
Suppressive dose	16
Tissue/Blood ratio	16
Hematotoxicity	16
Cholesterol Concentration	16
Delta Gm	16
Negation	16
HT50	16
ED2sec	16
Amount of Acotine used	16
Tidal volume	16
Alpha Ki	16
N/T	16
Reducing activity	16
BHIA50	16
Skin response	16
Hypocalcemic activity	16
Ratio I/P	16
HSA shift	16
fCmax/MIC	16
IC35	15
log(1/MEC)	15
Tmin	15
Kix	15
Uterus effect	15
I50 M	15
CFR rating	15
Log Ko/w	15
Serum T4	15
ME	15
Blood lactate	15
Behavioral syndrome	15
Progressed remission	15
Ts	15
Vm rel	15
No. of openarm entries	15
AV block	15
Infusion rate	15
Loss of affinity	15
T1/2 h	15
ED50 / ED50 (taxol)	15
No. of mice without tumors	15
IP+SC score	15
ED1/3	15
s-GPT level	15
s-GOT level	15
MeAIB uptake	15
DR20	15
Cmax/Tmax	15
Vmax / K	15
% release of nitric oxide	15
Log Pcyc	15
2 x APTT	15
pEC5	15
C10APD90	15
Max APD90 (delta)	15
Kh	15
NAD+ content	15
Epoxide formation	15
S-phase	15
Total binding inhibited	15
Reaction rate	15
Platelet count/ul	15
Kpol	15
K inact/Km	15
Lethal toxicity	15
Observed [pt]	15
No. of survivors/total	15
Average 14-day MGR	15
Remission	15
Peripheral restriction index	15
C 8 h	15
Toxic effect	15
T-cell	15
Log 1/KL	15
TD	15
GST activity	15
No. of invaded cells	15
TC50/IC50	15
Max protective effect	15
Negative ionotropic activity	15
Negative chronotropic activity	15
Ca2+ antagonistic activity	15
Absolute	15
AUC 100	15
Max agonist activity	15
Hepatic cholesterol	15
Hepatic triglyceride	15
IP3-sensitive Ca2+ stores	15
Bicarbonate level	15
Tubulin	15
No. of virus free mice	15
Infected	15
C2	15
Mean log LC50	15
Plasma MIC	15
SDS	15
Kf	15
Relative loss of potency	15
Log DSF	15
SWo	15
MRTV	15
X	15
Liver CH levels	15
Ambulation score	15
ICA	15
No. of avoidance	15
No. of escape failure	15
DBP/UP ratio	15
PPM	15
ABD50	15
EBD20	15
Sleep ratio	15
AUC ED50	15
Exudate volume	15
pK4	15
ED delta	15
Reduction in respiratory volume	15
1/n	15
pIC30	15
Free radical scavenging	15
No. of mice protected/tested	15
rK	15
Remaining compound	15
Caco-2 permeability	15
CLp	15
log(Tau/KA)	15
Max protection	15
Log2	15
GTP-gamma35S bound	15
p10 MIC	15
Insulin-sensitizing activity	15
Extent of skin lesions	15
No. of suncus vomited	15
Max fall in IOP	15
Fe removed	15
Tetramer	15
B-A/A-B	15
Thermodynamic solubility	14
PVCs	14
k3/k1	14
Free fraction	14
Vasopressor activity	14
Plasma total cholesterol	14
Surface involvement	14
Pka	14
FLT	14
Rn	14
Cdyn	14
Antidiuretic	14
Log Dmax	14
Ka1	14
CIC IC50	14
NTD50	14
-Log KD50	14
G1	14
Delta MA	14
Tissue levels	14
No. of scratches	14
Infectious virus	14
Maximum response	14
Transcriptional activity	14
k-2	14
kc	14
LambdaZ	14
pXI50	14
T99.9%	14
Increase in plasma lipase	14
Sp Max	14
Bullatacin index	14
UD	14
ED33	14
Log Pmic	14
Antimicrobial activity	14
k obs / concentration	14
C1.3	14
Relaxed DNA	14
Change in respiratory frequency	14
Change in tidal volume	14
Potentation	14
Net turns/min	14
10E2 k1	14
Progesterone production	14
CMV yield	14
Virus yield reduction	14
Profile	14
Decrease in No. of avoidence responses	14
T/C (survival)	14
KII	14
CPI	14
log10CFU/ml/day	13
t1/2lambda	13
MTT	13
IC50H	13
Choline uptake	13
Stroke volume	13
Relative cytotoxicity	13
Volume of urine	13
Bathochromic shift	13
Hypochromic shift	13
K app x10e6	13
CMpH	13
Migration	13
aPTT	13
Log 1/IC90	13
T>IC50	13
deltapIC50	13
MBIC=>90	13
C120/ED50	13
Lung weight	13
E100	13
Max enhancement	13
TO	13
T-cell binding	13
RBP	13
ILS (T/C)	13
Log cfu/g	13
Km'	13
[I] for Km'	13
HPB	13
PFU	13
Equilibrium	13
logED50	12
log10PFU	12
logPc	12
logt1/2	12
TLm	12
IC40	12
MNTD70	12
KI50	12
MTA	12
Oxidation	12
nKa	12
Gross morphology	12
IMPDH activity	12
Gastric damage	12
Cortex_Clearance	12
Antibody response	12
Protective dose	12
C6h	12
IVR	12
Atrial MAPD90	12
Ventricular MAPD90	12
Monocation species	12
Ksolv	12
Amount of TXB2 formation	12
ST elevation	12
increase in temperature	12
TEWL	12
5-HTP accumulation	12
Naproxen produced	12
Food	12
Fluid	12
Plasma triglyceride	12
Heart weight absolute	12
Relative	12
Relative TS	12
pKa6	12
Clones	12
Protein	12
Specific incorporation	12
Km/Ki	12
Cell Survival	12
DBP change	12
Liver concentration	12
Severity mean	12
PFC/splleen	12
T4	12
Paraparetic mice	12
Velocity relative to ATP	12
No. of mice infected /total	12
Acid titer	12
Changes in airway resistance	12
Changes in dynamic compliance	12
Change in volume	12
Change in foot-licking latency	12
Acute lethal toxicity	12
C5a affinity	12
Inhibition period	12
Aggregation ratio	12
Sign free dose	12
Depolarisation	12
Inhibitory binding	12
Concentration_urine	12
Intima area	12
Change of area	12
NAD+ level	12
ADP formation	12
Total rate	12
Relative efficiency	12
Log A50	12
Kimut/Kiwt	12
NMDA effect	12
KA effect	12
AMPA effect	12
Feces	12
Formation of NO3-	12
Formation of compound	12
C70	12
Residue fraction	12
Log [-10]	12
Log [-9]	12
Reduction in prostate weight	12
Punishment test msad	12
N20 formed	12
Basal GH	12
Agonistic potency	12
Venom	12
Relative initial slope	12
Carotid Flow Decrease	12
External nucleoside	12
Internalisation	12
Primary tumor weight	12
T.P.L	12
Displacement of DP	12
Behavior response	12
Basal binding	12
PAO activity	12
Rats turning	12
Of rats turning	12
Desensitisation	12
NOL	12
Relative initial rate	12
Ratio of dose	12
IUP	12
SHR	12
Peak effect time	12
Actual clearance	12
Ferret emesis	12
Relative phosphorylation rate	12
ECAR	12
C90	12
Max uterotonic response	12
Analogue level	12
Relative to control	12
Cytotoxicity IC50	12
Ks app	12
Growth response	12
Convulsions	12
GDP activity	12
Total release	12
delta Log P50	12
SA	12
Cyclase stimulation	12
EPS MED	12
Limiting t1/2	12
NB	12
Duration of seizure	12
MRTinf	12
BG	12
BG reduction	12
AUC glu	12
T1	12
MND	12
M/NTT	12
Irreversibility	12
M2/M1 Index	12
T/C (d)	12
KOH	12
Cholesterol content	12
MTD ratio	12
Intraperitonal score	12
Subcutaneous score	12
Radioactivity in urine	12
Mean axonal area	12
Axonal regeneration rate	12
DNA on filter	12
Log LC50	12
Relative threshold dose	12
Relative analgesic potency	12
Total DPM	12
Trans	12
Average for skin reaction	12
Relative permiability	12
Relative metabolic stability	12
pKH	12
pKL	12
Rate of turbidity change	12
Writhing number	12
Control of growth	12
Boron in media at 0h	12
Cellular uptake of boron at 16h	12
GI50/EC50	12
Remaining at 40 min	12
Change in tumor area	12
Time to peak tension	12
Duration of plateau	12
Decrease in tone	12
Tumor growth inhibition	12
Acetylation	12
GH peak	12
GH AUC 0-180	12
Rat turning	12
Average turns/first 15 min	12
Molar primaquine Index	12
No. cured/total	12
Amount of [3H]thymidine	12
Bitter taste intensity	12
Median tumoral volume	12
Time over 100ng/ml	12
C10 air/C10 N2	12
Cellular growth	12
Protein content	12
[LDH]max	12
[ALP]max	12
Analgesic response	12
PDC	12
Mean relative surviving fraction	12
CL(app)	12
Cminss	12
TD90	12
MBEC2	12
RH/RL	12
BsI	12
Log 1/E100	12
K L	12
Plasma lipid level	12
No. of animals protected/number of animals tested	12
AC	12
OSAV	12
Untreated control	12
No. of animals with damage	12
Amount of Ouabain used	12
Slope of Schild plot	12
Vaginal activity	12
T free	12
T bound	12
M/T	12
Change in MST	12
Active culture	12
HHP	12
Increase in [Ca+2]	12
Spermatogenic index	12
Interferon response	12
Pa	12
Cytotoxity	12
Peak inhibition	12
rapp	12
1/krel	12
Average ratio	12
graft survival	12
Reduction of IOP	12
Irritation of eyes	12
Iron binding	12
D2 selectivity	12
Ear thickness	12
Decrease of SBP	12
AD99	12
Respiratory system resistance	12
Age	12
amount in urine	11
Km app	11
delta logP	11
Mobilization	11
Occupancy	11
IOP lowering	11
Enantioselectivity coefficient	11
Residual amine (ee)	11
Epinephrine level	11
Erosions	11
Cartilage space	11
Mean paw diameter	11
rate constant app	11
Damage score	11
IPA	11
Binding site fraction	11
KNBP	11
Count	11
Minimum Tmax	11
Maximum Tmax	11
VmaxL	11
KmL	11
logBB	11
kHO	11
Relative concentration	11
Survival extension	11
Extent	11
Log Pion	11
Log P'	11
BGL	11
HAR	11
Change of predose	11
No. of vomiting episodes	11
KiA	11
Ratio_EC50	11
pFe3	11
Final plasma concentration	11
k2/KI	11
%T>MIC	11
AbsAC0.47_uM	11
logCMC	10
Cz	10
TED	10
TMSW	10
Phospholipidosis_MEC	10
Kuncat	10
-Log Ki	10
EPS	10
Max contractility	10
Zone reduction	10
pIC35	10
Adrenal uptake	10
Max score	10
Positive paws	10
Mitotic figures	10
Necrosis	10
Dilation	10
IPol	10
Decrease in CVR	10
No. of new tumors	10
No. of rats displaying DA syndrome	10
Isometric contraction	10
Morbidity	10
Correlation coefficient	10
Phosphorylation	10
p value	10
Increase contractility	10
damage reduction	10
High	10
Sigmap	10
Aqueous solubility	10
K cat	10
kobs	10
Tissue/Plasma Ratio	10
A2	10
Druguptake/dose	10
VRT(t)	10
MHC10	10
Vr	10
No. of untreated cells	10
PTZ	10
O2 consumption	10
kAH	10
kA-	10
k'o	10
Jss	10
Rate of rotation	10
AT1 affinity	10
k2 / Ki	10
pC30	10
Parasite suppression	10
Ac	10
Tc	10
Log 1/E50	10
pH1/2	10
Cytotoxicity index	10
Uterotropic activity	10
METD	10
Iron mobilization	10
C/I	10
Km x10e3	10
HA release	10
Ki(1.8x10e-11)	10
Rotations/10 h	10
Relative antitumor activity	10
Of dose excreted	10
log10PFU/ml	10
Parasitemia clearance after treatment	10
Parasitemia clearance after immunosuppression	10
PCR cure rate	10
CLblood	10
% bound	10
Cavg	10
LC10	9
LT99.9	9
Cp(f)ss	9
AC_50	9
logPi	9
Concentration_plasma	9
Recovered in urine	9
Binding Decrease	9
Day of vaginal opening	9
pIC50(mM)	9
SHR delta blood pressure	9
Log Poct C	9
n	9
Superoxide anion	9
Lysozyme release	9
Mean AUC	9
Mean ulcer index	9
Delta plasma cholesterol	9
TRAP staining	9
Skin Graft Survival	9
Behavioral observation	9
AUC second treatment	9
AUC first treatment	9
AUC total	9
Prolactin release rate	9
pKic	9
Dosage	9
Relative peroxidation	9
Time in light	9
Ratio plasma concentration/IC50	9
Survivals / total	9
Control survivals/total	9
Mineralizing apposition rate	9
NADH oxidn	9
CPCC	9
ID/thyroid	9
Vasopressor responses	9
Overt behavoiur	9
Animals protected	9
Alpha c	9
Weight reduction	9
Dioxygen uptake rate	9
CPmax	9
Amount of unreacted substrate	9
Unbound plasma	9
Plasma Insulin	9
Average IOP	9
Cumulative urine volume	9
NADH content	9
MGDH GI50	9
Empty	9
Max jumping rate	9
Zinc finger reactivity	9
ICL5	9
Mortality threshold	9
No. of protected animals/total	9
Reversing activity	9
Toxicity (deaths)	9
Activity (umol/mg.of protein. min)	9
Activity (nmol/mg.of protein. min)	9
No. of depolarizations	9
P/D	9
Threshold value	9
BMD	9
Susceptibilty Ratio (Liver/Intestine)	9
Tumour_[5-FU]	9
Plasma_[5-FU]	9
Ratio_tumour/plasma	9
Mean index	9
Thymus weight change	9
Nucleic acids	9
Glutathione	9
GR activity	9
pD10	9
Min plague Inhibitory	9
EF200	9
Cyotoxicity	9
Affinity state 1	9
Affinity state 2	9
Prostaglandin E2 level	9
Thromboxane B2 level	9
Total liver weight	9
Max aggregation	9
DDT msad	9
DLBT	9
HSF activity x10e2	9
Presumed drug-related deaths	9
Eff	9
Difference in retention time	9
Cell plating efficiency	9
Improved	9
Neutrophils	9
Eosinophils	9
T1/2 regen	9
Tumor latency	9
Tumor incidence	9
Tumor	9
pkb	9
Total no. of turns	9
Kiso	9
dPT	9
Histamine release	9
MTD/2	9
MTD/4	9
MTD/8	9
S/N	9
CR2	9
Cortical infarct volume	9
Affected animals	9
I.D./g tissue	9
Activation Factor	9
pKa app	9
K cat/Kinact	9
Ouabain dose	9
AUC glu reduction	9
Mean increase in survival	9
GD200 [d]	9
NAD content	9
B incorporation	9
Pleural volume	9
Paw weight	9
Toxic index	9
Learning time	9
Protection ratio	9
Topical irritation score(0-21)	9
Unchanged NDEA	9
Locomotion	9
Grip strength	9
Traction test	9
Protective ratio	9
Erythema formation	9
Inhibition at 5nM	9
K beta	9
Sterility	9
Reaction	9
ID100	9
Glucuronidation	9
Jmax	9
SUVmax	9
CLb	9
HC20	9
fIC30	9
fIC20	9
pEC99	9
Threshold concentration	9
Chelator	9
Decay-time constant	9
AUG	9
Simulation	9
LogD5.5	9
Vehicle control	9
Average weekly weight change	9
DeltaTm	9
Inhibitory rate	9
Rate of death	9
No. partial	9
SubG0	9
Approx. pKa	9
ST/CB ratio	9
Predrug	9
Postdrug	9
Fmut	9
Antiproliferative effect	9
Ka(T4)	9
IC05	9
logMEC	9
pKx	8
Drug mobility	8
LD40	8
IC27	8
Cmax_metabolite	8
Fold_increase	8
Agonist response	8
HR/chol	8
TSH/chol	8
MEC50	8
Kd'	8
Serum prolactin level	8
Augmentation	8
S/Cereb Ratio	8
S/CX Ratio	8
Dose converted	8
logD	8
Level of cGMP	8
Initial concentration	8
Apoptosis induction	8
Thymidine reversal	8
Catalase	8
LV	8
Relative activity of AChE	8
FD	8
ILS (mg/kg)	8
C24h	8
Tumor free/total	8
pH dependence	8
Prodrug reconversion	8
rel T	8
Fold stimulation	8
No. of guinea pigs protected	8
Carbamoylating activity	8
Total uptake	8
Fraction	8
DNA fraction	8
K DMPG	8
K DMPC	8
Krelative	8
CC50%	8
Brain/Plasma	8
Km(unbound)	8
AUMClast	8
Drug dissolution	8
Ratio of depolarizing activity	8
Uterotonic activity	8
Volume of air	8
Cumulative amount	8
Du	8
Helicity	8
LDL-C	8
EDmax	8
Boron incorporation	8
Log P/(100-P)	8
Arrhythmia score	8
MDA content	8
88Y-serum	8
ID/g femur	8
WBC x10e-3	8
Platelets x10e-3	8
RBC x 10e 3	8
alkaline phosphatase activity	8
Increase (Emax)	8
Mean reaction	8
Median retension latency	8
ITI activity	8
K m	8
Boron concentration	8
Relative to DA	8
Loss of inactivation	8
Log rate	8
Restoration	8
ED50 mg/kg	8
Skin scaling	8
Increase in LD50	8
TAD	8
ILS days	8
Average body weight	8
Average lung weight	8
No. of uptake sites	8
Peak striatal uptake	8
Unmetabolized	8
Plasma integral	8
Ulcer Index	8
-Log IC50/IC50	8
Time of half inactivation	8
Infertility activity	8
Margin before onset of tachycardia	8
Margin before onset of hypokalemia	8
Serum creatinine conc	8
Urea Nitrogen Concentration	8
ka/kr	8
kaKr/kr	8
Kr/kmax	8
1/kmax	8
kb	8
k eff	8
k eff (rel)	8
Total tritium	8
Total protein	8
Albumin	8
Hydroxyproline release	8
Creatinine_CL	8
Dose normalized clearance	8
Vdss/dose	8
F/dose	8
FICI90	8
FICI50	8
Vp/F	7
ft1/2	7
Ctau	7
Fapp	7
INCC50	7
B/P ratio	7
I/M ratio	7
I40	7
DA stim	7
Lactose production	7
Tubulin content	7
k3'	7
ClB	7
ClM	7
kC,U	7
Recovery rate	7
AUC ratio	7
Depression	7
fAUClast	7
KdH	7
KdL	7
fKi	7
MBIC80	7
MBEC99.9	7
2TT	7
Viral titer	7
Melanotropic activity	7
Melanotropic potency	7
ID50 mg/kg	7
Hypnosis potentiation	7
sigmaH	7
sigmaL	7
Uterotropic effect	7
Antiuterotropic effect	7
cell kill activity	7
Dead/treated	7
TD50/ED50	7
CLtotal	7
Unreacted drug	7
Pupil size	7
Erythema intensity	7
kH	7
Change in dP/dt	7
Mean aortic flow	7
Change in mean aortic flow	7
Change in stroke volume	7
Papps	7
rel ko	7
Brain uptake	7
Mean no. of days post-infection to death	7
ODC Activity	7
Cmin ss	7
EC300	6
LC15	6
FI50	6
DI50	6
Cmax_tumor	6
tz	6
CLup	6
Kkmax	6
ICdATP-50	6
Block of activity	6
Radioactive absorption	6
Tumor inhibition	6
SD200	6
Log Poct N	6
Log Poct Z	6
Log Pdod N	6
delta logPoct-dod	6
delta Log Doct-dod 7.4	6
DUR	6
HED	6
Inhibition concentration	6
Uterus to blood ratio	6
HF2	6
Tick action	6
Rate acceleration	6
Molarity	6
Stability of BSR	6
Time to 30% BSR	6
Time to righting	6
Weight change of AP-S	6
Apoptotic cells	6
Pro/Min/Enz	6
% injected dose/cm3	6
K4	6
No. of active/no. of tested	6
EU	6
Seizure stage	6
C5 min	6
CDOG	6
EIC50	6
pKa_decrease	6
Attacks	6
Control S/T	6
Average GI50	6
Anogenital distance	6
Sleep time	6
Cardiac contractile force	6
Left atrial pressure	6
Stroke work	6
DBP	6
MIW	6
Mean tumor delay	6
Vinact	6
LV DRxHR	6
EDP	6
TTC	6
IZ/AAR / AAR/LV	6
Max reversing rate	6
t0.9	6
Kds	6
Change in blood glucose	6
LV dP/dt	6
Media area	6
AUC inf	6
Sublethal dose	6
Average tumor weight	6
Non-specific binding	6
rel k	6
Relative cytotoxic activity	6
Excess MST	6
BQL	6
Inhibition (alpha = 0.01)	6
RTG	6
Mean tumor atency	6
Off-rate	6
K second	6
dpm bound to protein	6
K5	6
Average uterine weight	6
Sedative dose	6
Survivial / total	6
Stenosis	6
Transporter deg rate const (k)	6
Transporter production rate (r)	6
Tumor volume reduction	6
grade	6
Complete survival dose	6
FPT msad	6
Critical micelle concentration	6
Min ID	6
IO	6
ionization	6
Correct responses	6
kik0/Ki	6
pChange	6
K ACT	6
Polymorphonuclear cells	6
Last therapy day	6
pInhibition	6
Antagonist	6
FB	6
LL	6
Sni	6
Ya	6
Turns/1st	6
Bone damage score	6
Quench	6
keq	6
Parent remaining at time	6
Anti-Factor Xa activity	6
Rel brain exposure	6
APPTT	6
Occulations	6
MTD/16	6
Intake	6
Bile flow	6
SLI	6
EIR	6
Survivors at day 28	6
Cr leakage	6
[3H] thymidine cpm/dish	6
Elevation	6
Mean time to death	6
Level in serum	6
Weight ratio	6
K ass app	6
IUP AD50	6
2T11	6
pA2 app	6
LD50 x 1/10	6
LD50 x 1/20	6
LD50 x 1/40	6
GH	6
-Log K B	6
OT interval	6
Central selectivity	6
OT	6
Of tumors	6
ALT/GPT	6
K/10e4	6
-Delta G obs	6
Exhal+B1718ation of 14CO2	6
Ri	6
P-value	6
AED	6
No change	6
Exhalation of 14CO2	6
Intact	6
DOPAC concentration	6
Homovanillic acid concentration	6
LRR	6
RW	6
LPS	6
TDS ratio	6
Kinact/Ki	6
Elevation of threshold	6
DOPAC	6
HVA	6
Apoptotic cell	6
P7.4	6
Counts of rotation	6
Duration of anesthesia	6
Duration of increase in SLA	6
RIC50	6
Carnitine acetyl transferase	6
Enoyl-CoA hydratase	6
Palmitoyl-CoA oxid	6
Thrombin time	6
Paw edema	6
GAG	6
Femur weight	6
Mechanistic reference	6
K amine	6
PAR	6
Kkin	6
p24 synthesis	6
No. cured	6
Walking behaviour	6
Transfection activity	6
Decrease of spontaneous firing rate	6
Reduction in arterial blood pressure	6
Stimulations	6
Competitive protection	6
[3H]-uptake	6
Volume change	6
Rate change	6
RNA fraction	6
No. of rats with lesions	6
BUI	6
Relative uterotrophic activity	6
k x10e3	6
DR2	6
ROI	6
Plaque inhibition result	6
Ext AUC	6
Bone mineral density	6
Delyse	6
WBC_CHANGE	6
Change in hematology	6
BUN_CHANGE_BY	6
k_elim	6
CLint	6
Blood/Plasma ratio	6
pKinact	6
KD	6
MBC99	6
MBC<=99.9	6
PD100	6
Gastric score	6
Lesion coverage	6
Delta TG	6
Mean ED50	6
Log d50	6
d50	6
Blood loss	6
AUC units	6
50% naproxen formed	6
Initial heart rate	6
No. of foci per dish	6
Control cell number	6
Agonistic effect	6
Caverage	6
Kw	6
Cr secretion	6
Culture negative	6
Xi50	6
HDT	6
Body temperature drop	6
Body temp drop	6
Convulsion threshold	6
Distribution of excreted Fe	6
Rotorod index	6
GRI	6
Death dose	6
Serum glucose	6
Net Swelling	6
Relaxivity	6
AUC 1/T1	6
K obs x10e2	6
Relative Selectivity	6
No. of shocks accepted/5 min	6
Retraction time	6
TCT	6
Ratio_[3H]:tubulin	6
Ep2/2	6
Nitrite	6
Nitrate	6
IogP	6
RD100	6
t	6
Immunosupressive activity	6
Anti-fXa activity	6
Prolongation effect	6
Abortion	6
No. of relapses	6
PCP activity	6
Skin thickness	6
No. of infected cells	6
Antigen p24 content	6
RT activity	6
kONOO-	6
kred	6
Graft survival	6
Ability	6
Ki app (inact)	6
DOPA level	6
Cytotoxic effect	6
No. of occlusions	6
Plasma TC	6
Plasma TG	6
T>MIC90	6
CFU/g	6
Mem Rec	6
Tm(app)	5
fc max	5
f %t > MIC	5
IC50L	5
Kbb	5
AAC	5
Ki_app	5
Cmax_PTH	5
KD1	5
KD2	5
DA level	5
GSH reactivity	5
Loss of activity	5
k_2	5
PD'2	5
Hydrolysis rate constant	5
Decrease in heart norepinephrine	5
Decrease in hypothalamus norepinephrine	5
Rotational behavior	5
Increase in heart rate	5
Delta weight	5
Animals with palpable tumor	5
Max activation	5
Max potentiation	5
Thy-1 expression	5
KD hydro	5
Anesthetic effect	5
Lambda-z	5
lambda-z	5
Cp(f)max	5
pKR+	5
T>fEC50	5
fNOAEL	5
1/Vmax	5
MBEC80	5
fIC90	5
CLu/F	5
Delta S-H	5
Delta H-V	5
Delta CPP	5
AOC	5
Molar potency	5
No. of lung lesions	5
BAV	5
Inhibition of increase in weight	5
Cross reaction	5
LD/ED80	5
Lesion score	5
HTS data	5
Impaired	5
No. survived	5
Emesis_ED	5
Extent of DNA binding	5
Uptake rate	5
KHOX	5
Observed relaxivity	5
Khd	5
Substrate efficiency	5
[I] 0.5	5
IL-1 production	5
Antifungal activity	5
AG80	5
Aggregate	5
Fraction Recovered in urine	5
Amount Recovered in urine	5
log(1/IC50)	4
fc max/MIC	4
CLd	4
Cmin_PBMC	4
[A]T,L	4
deltaTCID50	4
ED97	4
Blockage	4
fm	4
Serum LH level	4
Utreotropic effect	4
IC50/EC50	4
Permeability index	4
Total glomeruli	4
Median tumor	4
Time spent	4
No. of culturesactive/total	4
Anti-emetic	4
Anti-analgesic	4
Anticonvulsant	4
Max plasma level	4
Extraction ratio	4
Blockade effect	4
Rlung	4
CLT	4
Staining	4
CI50	4
No. active	4
Allodynia score	4
RVCF	4
CSF levels	4
TF/P	4
SNGFR	4
Survival after 30 days	4
Max fold increase	4
Gross kill	4
Plasma [14C] cholesterol	4
ACAT activity	4
Therapeutic dose	4
fp	4
Brain	4
Gross log kill	4
I14	4
Treatment	4
NaCl concentration	4
Decrease in life span	4
Median day of survival	4
Average max	4
Total urine activity	4
DL50	4
Haptoglobin	4
Synaptic site	4
Receptor state	4
Inhibition tumor index	4
CFU-GEMM	4
Penetration	4
AUC nom	4
Responder	4
Concentration in Brain	4
TRIG_CHANGE	4
CHOL_CHANGE	4
PHOSLPD_CHANGE	4
ALB_CHANGE	4
CREAT_CHANGE_BY	4
Plasma magnesium_CHANGE_BY	4
Change in spermatogenesis	4
IC0.2	4
EAUC50	4
Qmax	4
HC90	4
IC37	4
EC70	4
Conc_brain	4
LZ	4
FT50	4
fpIC50	4
Permeability rate	4
MTD/ TGI50	4
Active	4
Po/w	4
Critical concentration	4
Log inhibition	4
Lowering activity	4
Antiviral selectivity	4
c.v	4
Binding potency	4
Functional selectivity	4
LV dP/dtmax	4
ED30 DBP	4
ED10 HR	4
Drug Conc (serum)	4
Drug Conc (LDL)	4
Molar content	4
Lipid peroxidation	4
Lesion	4
kirr	4
Fraction change	4
K'i	4
Ki/K'i	4
Cooperative effect	4
IH50	4
No. of WDS/60 min	4
TCI	4
Response value	4
Ratio of stimulation	4
Body temperature	4
Hypokinesia	4
Ring immobility	4
Tail flick	4
Water intake	4
ko	4
DA/NE ratio	4
Vacuole response	4
ALT.	4
Test	4
Ratio (Ci/Ce)	4
Retches	4
Vomits	4
Control retches	4
Control vomits	4
Reduction in EOS count	4
EOS inhibition	4
ED50 mg/animal/day	4
% of NO release	4
F1/2	4
T3/4	4
F3/4	4
Activity Factor	4
Plasma half-life	4
Activity Score	4
Serum creatinine	4
PP2A Selectivity	4
NAD	4
Thylpositive cells	4
Thylpositive cells/spleen	4
CTC50	4
Clonic	4
Antifertility activity	4
Tonic	4
Induction of catalepsy	4
Decrease in arterial blood pressure	4
kp	4
g/30min	4
Kin x	4
Optimum T/C	4
Max mean weight loss	4
PD 50	4
T/C (tumor vol)	4
SPB	4
MBEC90	4
Vi	4
Cmin(84hr)	4
LC25	3
UC50	3
deltalog10CCID50	3
Decreased_triglyceride	3
Fraction cleared renally	3
AUIC	3
Ratio_liver/blood	3
Topical dosage	3
EC90/MIC	3
pKa BN	3
pKa AZ	3
pKa BZ	3
pKa AN	3
Log KZ	3
Log Poct A	3
No effective/ no. tested	3
Chemosensitizing activity	3
Potency Ratio	3
Ccontrol	3
Increase in MAP	3
10E2 K1	3
behavioral observation	3
Vmax rel	3
Vel rem	3
Pharmacokinetic	3
Prolactin release	3
Acid hydrolysis	3
AFLCl	3
Antipsychotic	3
Molar ratio	3
Sleep latency	3
REM latency	3
Performance	3
ID/animal	3
5-HT Level	3
CFR	3
C1	3
T/C @ 50mg/kg	3
T/C @ 40mg/kg	3
T/C @ 30mg/kg	3
T/C @ 20mg/kg	3
Cures@ 40 mg/kg	3
Cures@ 20mg/kg	3
Cures@ 10mg/kg	3
Cures@ 80 mg/kg	3
Cures@ 40mg/kg	3
Effllux	3
Anxiolytic activity	3
ET-1 level	3
Weight increase	3
Liphophilicity	3
PAP	3
Anxiolytic affect	3
Volume reduction	3
LDH50	3
Stimulatory effect	3
Anticonvulsant activityAnticonvulsant activity	3
No. of axonal branchpoints/cell	3
Max contractile activity	3
P Increase	3
Relative inactivation	3
LA	3
Tm shift degreeC	3
ILS (Sur)	3
Pressure response	3
PActivity	3
P-450 loss	3
Heme loss	3
Infection score mean	3
K obs / s	3
[Ca2+]	3
MPA	3
ILA	3
pK3'	3
LV dp/dt	3
EFF+/-SD	3
NBT reduction	3
Variation of edema volume	3
pWeight change	3
AbA/analogue ratio	3
Increased	3
PCaco-2	3
Killed	3
Weight (mg/g)	3
UV	3
BBB Impermeable	3
Ki obs / [I]	3
Delta non HDL-C	3
Anticoagulant activity	3
K inact/I	3
Reduction of prostate weight	3
Synergistic effect	3
IFN gamma concentration	3
Log Kill	3
Log KB	3
Peak GH	3
Fold IC50	3
FRP at 10microM	3
L	3
Average bile flow	3
Median toxicity	3
Generalization	3
AD100	3
Curative Index	3
eduction	3
KD non ionic	3
Ki/ki	3
kmax/KS	3
kmax	3
KS	3
30 day survival/total	3
T1/2 beta	3
V1	3
V2	3
Permeability limited	3
Blood Pressure	3
Antagonist efficacy	3
1/2Kcat/Km	3
-Log Kb	3
Cell density	3
Gastric lesions	3
Control at the dose of 5.0microg/mouse	3
Control at the dose of 50.0microg/mouse	3
Max APD95	3
Locomotor	3
BSA binding	3
GI clearence	3
GTPshift	3
[3H] thymidinecpm/dish	3
Remained	3
Mean effective dose	3
3.3	3
duration of action	3
Relation	3
Of viability	3
SCW reduction	3
Delta beats/min	3
AUC glu reduction(mM x min)	3
BP (ED50)	3
g/mouse	3
AE score	3
GC200 [d]	3
Twitch tension	3
K B	3
Replacement	3
Anti-arhythmic	3
food intake	3
Onset for sleep, min	3
pCB	3
KNa	3
Resistance ratio	3
Toxicity index	3
ED58	3
Reduction in respiratoryvolume	3
PD' 2	3
P50C	3
K act	3
kIAM'	3
Colonic weight	3
KR	3
kR	3
Serum TSH	3
RPE	3
delta pKa	3
PSA	3
Tumor weight reduction	3
Max displacement	3
Basal activity	3
Hours above EC90	3
Uterine weight effect	3
CIT	3
Glutathione levels	3
Hepatic extraction	3
CLr	3
LUI	3
t1/2ss	3
Cp(f)/dose	3
Druguptake(free)/dose	3
pMED	3
BBB	3
S20,w	3
deltaCT	3
log10 TCID50	3
Change in myocardial conduction	3
Abolition	3
Varea	3
Bacterial growth	3
K SH	3
sigmaSH	3
Heart beat	3
Therapeutic indices	3
Total coenzyme	3
RBA data	3
Average food intake	3
Average sample intake	3
pKa value	3
Degrees Centigrade	3
Day of death	3
Net log change in tumor burden	3
Tumor free survival	3
Acetylcholine release	3
QTc Interval	3
Ventricular relative refractory period	3
([I]/[S]0.5)	3
Ion enhancement	3
Rate of recovery	3
Fana	3
Pregnancy index	3
Rate of [Ca+2] increase	3
FPGS activity	3
Degree of cross resistance	3
DBP15	3
Ca2+ excretion	3
CLd/F	3
Activity EC50	3
kel	3
Q50	3
C ss	3
E2:E1	3
Kinetic_solubility(app)	2
alphat1/2	2
PA	2
MC100	2
reduction in CL_renal	2
C50g	2
Hg	2
C50k	2
Hk	2
Kgmax	2
Cmax_triphosphate	2
Antihypertensive	2
Relative oncentration	2
Time of dosing before antigen challenge.	2
Asorbance	2
average log GI50	2
T/C value	2
pDelta IOP	2
T1/2 iv	2
KinX	2
Log of inhibitory zone	2
TID20	2
k3/K1	2
Liver catalase	2
Oral dose	2
pinhibition	2
Clinical reference	2
U/P	2
Analgesicactivity	2
Blood volume	2
Mortality ratio	2
Inhibitory dose	2
GI tolerance	2
Intrinsic	2
Second order	2
I28	2
Reduction in blood pressure	2
Reduction in heart rate	2
Decreace in BP	2
I42	2
I5	2
I13	2
I7	2
Relative Vmax/Km	2
% dose	2
I16	2
2xAPTT	2
Initial inhibition	2
Control level	2
Cell death	2
Inhibition at 10nM	2
Log Ke	2
Change in DA synthesis	2
Kiact	2
PKb	2
Tissue weight	2
Molar equivalence bound	2
Elimination	2
Change in density of uterine gland	2
CLt/F	2
logP	2
deltapH	2
EC16	2
HC>=50	2
T>EC50	2
CI90	2
CI75	2
CI95	2
NcoR1_recruitment	2
Reduced_circadian_oscillation	2
Reduced_Cyp7a1_gene_exp	2
Reduced_Srebf1_gene_exp	2
Reduced_Serpine1_gene_exp	2
WCC99.9	2
EC50H	2
EC50L	2
EmaxH	2
EmaxL	2
pH50	2
BmaxL	2
BmaxH	2
fLOAEL	2
MBEC50	2
MIC98	2
LD16	2
LD84	2
fEC85	2
Poct	2
BSR	2
Max BSR	2
Time to max. BSR	2
Inhibition at 1uM	2
Accumulated counts/30	2
Average gross pathology scores+/- SE	2
Relative antiandrogenic activity	2
POE score	2
Mean KD	2
Contractile force	2
CPD50	2
Resorption	2
Exudate	2
Specific binding per mg of protein	2
Max inhibition concentration	2
Bacterial counts	2
Occlusion time	2
Arterial occlusion	2
Carotid flow reduction	2
Mean day	2
Plasma Ca2+	2
Kidney VDR	2
1/Ki	2
Time of peak action	2
Duration of peak action	2
Ke selectivity ratio	2
inhibition (at 100uM)	2
Insulin lowering effect	2
Days to tumor doubling	2
Log P/Log D	2
Ka app	2
Group performance time	2
k2/Ks	2
(kcat/KM)/kuncat	2
EF90	2
H2 activity	2
KbS	2
PS	2
Bactericidal	2
Monomer	2
Vmax (uM)	2
Injected dose (g)	2
AlDH activity	2
LD30	2
I10	2
Dissociation	2
T1/2 h/s	2
T1/2 h/min	2
QA	2
Photoxic reaction	2
Ki comp	2
Ki' uncomp	2
Dispacement	2
Time after dose	2
KBp	2
Fmean	2
HD40	2
135	2
Concentration of Cl-	2
Cmax (Ratio)	2
CS50	2
Fraction excreted unchanged	2
fVdss	2
log1/S	2
MIC97	2
Tmax/dose	2
Report	2
alphat1/2(app)	2
CL-renal	2
Ratio AUC(inf)	2
Css min	2
Css-4w	2
Css-12w	2
Css-48h	2
Compound Recovery	2
Total CL	2
IC33	1
A ctivity	1
CIC95	1
%AUC	1
%Cleared	1
tCmax	1
Log EC50(uM)	1
Log IC50(uM)	1
Activ ity	1
Activit y	1
%hepatic blood flow	1
Ratio_Cmax_brain/plasma	1
%Remaining	1
Vdss(app)	1
Recovered in bile	1
Clearance_blood	1
Anabolic activity	1
%Bound_Albumin	1
Fraction of Liver Blood Flow	1
Tumour inhibition	1
1/Km	1
LDLO	1
Ultrafiltration	1
Halucinogenic activity	1
I23	1
ILSmaxOD	1
GR control	1
-Log LC50	1
Ki inact	1
pKa E2	1
N/D	1
DeltaBP	1
Pka2	1
Stimulatory activity	1
Relative stimulatory activity	1
Rate of metabolism	1
Cbrain	1
Terminal elimination t1/2	1
Terminal t1/2	1
Range of MIC	1
Increases	1
ALP_CHANGE_TO	1
ECG	1
Cmin(1)	1
Cmin(ss)	1
Cav(ss)	1
AUC(0-24) normalised	1
AUCss(tau) normalised	1
Hepatic blood flow	1
Change in ovarian follicular atresia	1
Change in corpora lutea	1
K1/2	1
MIC82	1
CC75	1
t1/2eff	1
EC24	1
t1/2(app)	1
fIC80	1
C0(unbound)	1
Relative weight loss	1
Plasma_triglyceride	1
Plasma_cholesterol	1
Plasma_NEFA	1
Plasma_glucose	1
Plasma_insulin	1
Plasma_leptin	1
Plasma_IL-6	1
fMEC	1
LCC99	1
LCC99.9	1
MBIC100	1
MBC100	1
No. of rats died	1
Log K4	1
Average peak Concn	1
Radioactivity remained	1
IN	1
ER/PR	1
KdSPR	1
Paw volume	1
KdSPA	1
n/N	1
EC14	1
Anti-HIV activity	1
Ventricular tachycardia	1
pRatio	1
Spontaneous reperfusion	1
I20	1
Opsin shift activity	1
Mean maximumtemp drop	1
% reduction	1
I30	1
Cataleptic effect	1
Anticancer activity	1
No_cures	1
VSV	1
VV	1
Cytocidal effect	1
Ti	1
delta Vmax	1
CIp	1
Vd area	1
Ratio of distribution	1
Adverse effect	1
Ki0	1
PkB	1
ppKb	1
Survival dose	1
Glucose lowering ob/ob dose	1
Relative contractile potency	1
Basal glucose	1
Net body weight delta	1
Drug	1
Hypoglycemic	1
Glucose lowering relative to positive control	1
k12	1
k21	1
ID60	1
Dose non renally cleared	1
EC99.6	1
EC98.6	1
EC91	1
ECMax	1
AC30	1
EC25(unbound)	1
pKb(app)	1
Kup	1
EC170	1
% inhibition in spleen	1
% inhibition in liver	1
% inhibition in bone-marrow	1
Kmax	1
pKa(1)	1
Protein bound	1
Vd app	1
C(24h)	1
Vd(app)	1
Cmin(80hr)	1
Apparent_pKa	1